Sa A Wang, M.D.

Peer-Reviewed Articles

1. Foucar K, Bagg A, Arber DA, Bueso-Ramos CE, Geyer JT, Hasserjian RP, Orazi A, Reichard KK, Tam W, Wang SA, Weinberg OK, Hsi ED. Isolated KRAS and NRAS mutations in adults with monocytosis and/or cytopenia(s), 2025. PMID: 41437825.
2. Wei Q, Pemmaraju N, Wang SA, Hu S, DiNardo C, Issa GC, Bueso-Ramos CE, Xu J, Li S, Medeiros JL, Tang G. Acute myeloid leukemia with t(10;17)(p15;q21)/ ZMYND11::MBTD1: a subtype with minimal differentiation, CD7/CD56 expression, and generally poor outcomes in adults, 2025. PMID: 41262054.
3. Ok, CY, Natu, A, Daneshpajouhnejad, P, Fathalla, LA, Symes, E, Barone, PD, Shestakova, A, Foucar, K, Bueso-Ramos, CE, Montalban Bravo, G, Orazi, A, Patnaik, MM, Hasserjian, RP, Arber, DA, Geyer, JT, Bagg, A, Reichard, KK, Wang, S. Chronic myelomonocytic leukemia in the young (aged 50 years and younger). Cancer 131(22), 2025. e-Pub 2025. PMID: 41236405.
4. Nirmalanantham P, Quesada AE, Ghosh A, Lin P, Ok CY, Yang RK, Fang H, Garces S, Kanagal-Shamanna R, Loghavi S, Routbort MJ, Yin CC, Wei W, Pasyar S, Bassett R, Hussein SE, Jain N, Burger J, Wierda WG, Wang S, Bueso-Ramos C, Patel KP, Medeiros LJ, Jelloul FZ. Mutational Landscape and Clinical Impact of SPEN Mutations in Patients with Chronic Lymphocytic Leukemia, 2025. e-Pub 2025. PMID: 41228377.
5. Shuyu E, Vega F, Khanlari M, Fang H, Xu J, Li S, Hu S, Wang SA, Wei Q, Wang WJ, Medeiros L, Wang W. BCL11B helps to define T-lineage in lymphomas/leukaemias with a mixed/ambiguous immunophenotype. Pathology 57(6):746-752, 2025. e-Pub 2025. PMID: 40318959.
6. Wei Q, Wang SA, Garcia-Manero G, Kanagal-Shamanna R, Toruner GA, Hu S, Loghavi S, Ok CY, Medeiros L, Tang G. Optical Genome Mapping in Myelodysplastic Syndromes: Clinical Value and Limitations Derived from a Cohort of 236 Patients. Modern Pathology 38(10), 2025. e-Pub 2025. PMID: 40780682.
7. Kwon AJ, Cantu MD, Madanat YF, Hasserjian RP, Koduru P, Wang S, Tang G, Weinberg OK. Trisomy 8 in De Novo Acute Myeloid Leukemia Lacking MDS-Related Cytogenetics Does Not Significantly Influence Survival. International Journal of Laboratory Hematology 47(5):884-890, 2025. e-Pub 2025. PMID: 40419386.
8. Azevedo, RS, Wang, S, Swanson, DM, Daver, N, Pemmaraju, N, Kadia, TM, Issa, GC, Yilmaz, M, Borthakur, G, Senapati, J, Jen, WY, Short, NJ, Ravandi-Kashani, F, Wang, W, Fang, H, Xu, J, Patel, KP, Tang, G, Medeiros, LJ, DiNardo, C, Loghavi, S. CD123 expression and its correlation with mutation profile in acute myeloid leukaemia. British Journal of Haematology 207(4):1648-1652, 2025. e-Pub 2025. PMID: 41070667.
9. Wang WJ, Wang SA, Fang H, Wei Q, Jorgensen JL, Hu S, Xu J, Li S, Tang G, Tang Z, Medeiros L, Wang W. Immunophenotypic, cytogenetic, and mutational features of chronic lymphocytic leukemia/small lymphocytic lymphoma with atypical immunophenotype. Cytometry B Clin Cytom, 2025. e-Pub 2025. PMID: 40814768.
10. A Bazinet, S Loghavi, Wei Y, Bataller A, Sasaki K, Arani N, Darbaniyan F, Chien K, Hammond D, Bouligny I, Kanagal-Shamanna R, Thongon N, Tang G, Urrutia S, Kadia T, DiNardo C, Daver N, Short N, Issa G, Pemmaraju N, Jabbour E, Wang SA, Wang W, Borthakur G, Bueso-Ramos C, Ravandi F, Medeiros L, Kantarjian H, Garcia-Manero G, # GM. Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy. Leukemia 39(9):2256-2265, 2025. e-Pub 2025. PMID: 40691503.
11. Wang, W, Czader, M, Wang, S. Blood- and bone marrow–based mature T-cell and natural killer cell leukemias and lymphomas. American journal of clinical pathology 164(1):7-25, 2025. e-Pub 2025. PMID: 40646680.
12. Wang SA, Li S, Wang W, Xu J, Thakral B, Hu S, Ok CY, Jia F, Jorgensen JL, Medeiros L, Ravandi F, Short NJ, Loghavi S. Technical and Clinical Validity of Assessing Measurable Residual Disease by Multicolor Flow Cytometry in an Unselected Acute Myeloid Leukemia Patient Cohort, 2025. e-Pub 2025. PMID: 40522873.
13. Shuyu, E, Medeiros, LJ, Fang, H, Li, S, Tang, G, Wang, S, Wang, W, Yin, CC, You, MJ, Iyer, SP, Malpica Castillo, LE, Qiu, L, Tang, Z, Wei, Q, Lin, P, Xu, J. Low CD25 in ALK+ Anaplastic Large Cell Lymphoma Is Associated with Older Age, Thrombocytopenia, and Increased Expression of Surface CD3 and CD8. Cancers 17(11), 2025. e-Pub 2025. PMID: 40507248.
14. Saul EE, Urrutia S, Yang H, Montalban-Bravo G, Tang G, Toruner G, Patel K, Luthra R, Bueso-Ramos C, Wang SA, Chien K, Sasaki K, Atluri H, Goulart H, Thakral B, Garcia-Manero G, Kanagal-Shamanna R. A Case of Cryptic CBFB::MYH11 Acute Myeloid Leukemia With Noncanonical Breakpoints Detected by Optical Genome Mapping. JNCCN Journal of the National Comprehensive Cancer Network 23(6), 2025. e-Pub 2025. PMID: 40345240.
15. DiNardo, C, Jen, WY, Takahashi, K, Kadia, TM, Loghavi, S, Daver, N, Xiao, L, Reville, PK, Issa, GC, Short, NJ, Sasaki, K, Wang, S, Mullin, JK, Pierce, S, Bradley, C, Borthakur, G, Maiti, A, Alvarado, Y, Pemmaraju, N, Ferrajoli, A, Swaminathan, M, Ohanian, M, Abbas, HA, Hammond, D, Burger, JA, Haddad, FG, Montalban Bravo, G, Chien, KS, Masarova, L, Yilmaz, M, Jain, N, Andreeff, M, Garcia-Manero, G, Kornblau, SM, Ravandi-Kashani, F, Jabbour, EJ, Konopleva, M, Kantarjian, HM. Long term results of venetoclax combined with FLAG-IDA induction and consolidation for newly diagnosed and relapsed or refractory acute myeloid leukemia. Leukemia 39(4):854-863, 2025. e-Pub 2025. PMID: 40000842.
16. Hu Z, Yin CC, Sun X, Han X, Wang W, Wang S, You MJ. A diagnostic dilemma for a patient with skin lesions and marked leukocytosis: mixed-phenotype acute leukaemia or blastic plasmacytoid dendritic cell neoplasm with aberrant cytoplasmic CD3 expression?. Pathology 57(3):371-374, 2025. e-Pub 2025. PMID: 39701847.
17. Shuyu E, Jelloul FZ, Nahmod KA, Short N, Leventaki V, Jia F, Xu J, Loghavi S, Wang W, Jabbour L, Tang G, Medeiros L, Wang SA. Acute lymphoblastic leukaemia with T- and B-lineage defining markers, 2025. e-Pub 2025.
18. Wei Q, Jelloul FZ, Wang SA, Tang G, Li S, Lin P, Loghavi S, Wang H, Medeiros L, Xu J. Concurrent Bone Marrow Acute Undifferentiated Leukemia and Mediastinal T-Lymphoblastic Lymphoma With Identical SET::NUP214 Fusion and PHF6 and EZH2 Mutations, 2025. PMID: 40264515.
19. Wei, Q, Toruner, GA, Thakral, B, Patel, KP, Pemmaraju, N, Wang, S, Kanagal Shamanna, R, Tang, G, Issa, GC, Loghavi, S, Medeiros, LJ, DiNardo, C. Cryptic KMT2A::AFDN Fusion Due to AFDN Insertion into KMT2A in a Patient with Acute Monoblastic Leukemia. Genes 16(3), 2025. e-Pub 2025. PMID: 40149468.
20. Jen, WY, Sasaki, K, Ravandi-Kashani, F, Kadia, TM, Wang, S, Wang, W, Loghavi, S, Daver, N, DiNardo, C, Issa, GC, Abbas, HA, Nasnas, C, Bataller Torralba, A, Urrutia, S, Karrar, OS, Pierce, S, Kantarjian, HM, Short, NJ. Impact of measurable residual disease clearance kinetics in patients with AML undergoing intensive chemotherapy. Blood Advances 9(4):783-792, 2025. e-Pub 2025. PMID: 39631072.
21. Kirtek, T, Chen, W, Harris, J, Bagg, A, Foucar, K, Tam, W, Orazi, A, Hsi, ED, Hasserjian, RP, Wang, S, Ng, DP, George, T, Shi, M, Reichard, KK, Symes, E, Zhang, X, Arber, DA, Weinberg, OK. Acute Leukemias of Ambiguous Lineage With MDS-Associated Mutations Show Similar Prognosis Compared to Acute Myeloid Leukemia With MDS-Associated Mutations. American journal of hematology 100(2):300-304, 2025. e-Pub 2025. PMID: 39578955.
22. Hong Fang, DW, Ok, CY, Jorgensen, JL, Medeiros, LJ, Wang, W, Wang, S. Advancing Diagnostic Accuracy and Quality of Patient Care Through the Implementation of a Flow Cytometry Quality Assurance Program. Archives of Pathology and Laboratory Medicine 149(2):e26-e30, 2025. e-Pub 2025. PMID: 38871355.
23. Shuyu, E, Xu, J, Wang, S, Tang, G, Jabbour, EJ, Li, S, You, MJ, Medeiros, LJ, Yin, CC. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor acute lymphoblastic leukemia. American journal of clinical pathology 163(2):231-239, 2025. e-Pub 2025. PMID: 39235991.
24. Xu, J, Kim, DH, Wang, W, Li, S, Lin, P, Tang, G, Konoplev, SN, Qiu, L, Fang, H, Garces, S, Leventaki, V, Shuyu, E, Medeiros, LJ, Wang, S. Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation. American journal of clinical pathology 163(2):240-250, 2025. e-Pub 2025. PMID: 39244687.
25. Kim, DH, Medeiros, LJ, Xu, J, Tang, G, Qiu, L, Wang, S, Ok, CY, Wang, W, Yin, CC, You, MJ, Garces, S, Lin, P, Li, S. Diffuse Large B-Cell Lymphoma/High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements. Modern Pathology 38(5), 2025. e-Pub 2025. PMID: 39805522.
26. Dimopoulos, YP, Wang, W, Wang, S, Loghavi, S, DiNardo, C, Gerstein, YS, Hu, S, Tang, Z, Ilagan, CL, Thakral, B, El Hussein, S, Xu, J, Li, S, Lin, P, Patel, K, Ok, CY, Medeiros, LJ, Fang, H. The spectrum of hematologic neoplasms in patients with Li-Fraumeni syndrome. American journal of hematology 99(12):2416-2419, 2024. e-Pub 2024. PMID: 39392132.
27. Nahmod KA, Miranda RN, Vega F, Thakral B, Pemmaraju N, Montalban-Bravo G, Loghavi S, Jelloul FZ, Wang W, Wang S, Muzzafar T, Patel K, Bueso-Ramos CE, Medeiros LJ, Kanagal-Shamanna R. Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation: report of two cases with literature review. Leuk Lymphoma:1-9, 2024. e-Pub 2024. PMID: 39704386.
28. Sameeta F, Wang W, Jelloul FZ, Nwogbo OV, Thakral B, Xu J, Li S, Ok CY, Tang G, Jia F, Medeiros L, Loghavi S, Jorgensen JL, Wang SA. The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic Syndromes, 2024. e-Pub 2024. PMID: 39711284.
29. Hamdan H, Liu YC, Wang SA, Bledsoe J, Chisholm KM, Siddon A, Ohgami R, George TI, Kurzer J, Hasserjian RP, Arber DA, Bagg A, Foucar K, Margolskee E, Laczko D, Chen W, Fuda F, Aggarwal N, Weinberg OK. Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56-positive acute leukemias, 2024. e-Pub 2024. PMID: 39866946.
30. Sameeta, F, Wang, S, Tang, Z, Khoury, JD, Fang, H, Wang, D, Xu, J, Li, S, Hu, Z, Hu, S, Jorgensen, JL, Medeiros, LJ, Wang, W. Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement. American journal of clinical pathology 162(5):455-463, 2024. e-Pub 2024. PMID: 38801226.
31. Kim, DH, Jia, F, Patel, KP, Bose, P, Wang, S, Bueso-Ramos, CE, Ok, CY. Utility of KIT Mutations in Myeloid Neoplasms Without Documented Systemic Mastocytosis to Detect Hidden Mast Cells in Bone Marrow. Clinical Lymphoma, Myeloma and Leukemia 24(11):e878-e882, 2024. e-Pub 2024. PMID: 39107203.
32. Zhao, X, McCall, CM, Block, JG, Ondrejka, SL, Thakral, B, Wang, S, Al-Ghamdi, YA, Tam, W, Coffman, B, Foucar, K, Daneshpajouhnejad, P, Bagg, A, Lin, F, Hsi, ED. Expression of CD6 in Aggressive NK/T-cell Neoplasms and Assessment as a Potential Therapeutic Target. Clinical Lymphoma, Myeloma and Leukemia 24(11):e808-e818, 2024. e-Pub 2024. PMID: 39089930.
33. Nasnas, PE, Ling, J, Gerstein, YS, Wang, S, Loghavi, S, Hammond, DE, Montalban Bravo, G, Senapati, J, Pemmaraju, N, Corredor, J, Pierce, S, Roth, M, Ravandi-Kashani, F, Cuglievan, B, Kadia, TM, DiNardo, C. Detection of PNH Clones can Aid in the Distinction of Aplastic Anemia vs Inherited BM Failure Syndromes. Clinical Lymphoma, Myeloma and Leukemia 24(10):732-735, 2024. e-Pub 2024. PMID: 38945779.
34. Loghavi, S, Wei, Q, Ravandi-Kashani, F, Quesada, AE, Routbort, MJ, Hu, S, Toruner, GA, Wang, S, Wang, W, Miranda, R, Li, S, Xu, J, DiNardo, C, Daver, N, Kadia, TM, Issa, GC, Kantarjian, HM, Medeiros, LJ, Tang, G. Optical genome mapping improves the accuracy of classification, risk stratification, and personalized treatment strategies for patients with acute myeloid leukemia. American journal of hematology 99(10):1959-1968, 2024. e-Pub 2024. PMID: 39016111.
35. Hamilton MJ, Greene LW, Madigan LM, Wang SA, Arana Yi C, Kuykendall A, George TI, Castells MC. Case Report: Multidisciplinary management of a patient with indolent systemic mastocytosis and refractory symptoms. Front Allergy 5:1401187, 2024. e-Pub 2024. PMID: 39493747.
36. Crane, GM, Geyer, JT, Thakral, B, Wang, S, Wool, GD, Li, KD, Davis, AR, Boiocchi, L, Bosler, D, Bueso-Ramos, CE, Arber, DA, George, T, Bagg, A, Hasserjian, RP, Orazi, A, Hsi, ED, Rogers, HJ. Predictors of clinical outcome in myeloproliferative neoplasm, unclassifiable. American journal of clinical pathology 162(3):233-242, 2024. e-Pub 2024. PMID: 38597584.
37. Sameeta, F, Fang, H, Wang, W, Tang, Z, Wang, S, Toruner, GA, Parisi, X, Khoury, J, Issa, GC, Garcia-Manero, G, Medeiros, LJ, Tang, G, Loghavi, S. Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma. American journal of hematology 99(9):1827-1829, 2024. e-Pub 2024. PMID: 38440855.
38. Marvin-Peek J, Jen W, Kantarjian HM, McCue D, Haddad FG, Wierda W, Ferrajoli A, Burger J, Abusab T, Jorgensen J, Wang SA, Patel K, Loghavi S, O'Brien S, Ravandi F. Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia, 2024. PMID: 38749022.
39. Kim, DH, Wang, S, Wang, W, Tang, G, Li, S, Yin, CC, Lin, P, Konopleva, MY, You, MJ, Miranda, R, Wang, X, Wei, Q, Medeiros, LJ, Xu, J. Acute myeloid leukemia with mast cell differentiation is characterized by interstitial mast cells, complex karyotype, TP53 alterations and poor prognosis. Haematologica 109(8):2711-2715, 2024. e-Pub 2024. PMID: 38546693.
40. E S, Tang G, Li S, Schlette E, Wang SA, Xu J. Anaplastic large cell lymphoma with ATIC::ALK in leukemic phase and associated with hemophagocytic lymphohistiocytosis. Int J Lab Hematol 47(1):13-14, 2024. e-Pub 2024. PMID: 39109887.
41. Alqahtani, S, Ramakrishnan, R, Shuyu, E, Wang, S, Nunez, CA, McCall, DC, Garcia, MB, Roth, M, Cuglievan, B, Gibson, A. Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia. Pediatric Blood and Cancer 71(8), 2024. e-Pub 2024. PMID: 38837565.
42. Bazinet, A, Wang, A, Li, X, Jia, F, Mo, H, Wang, W, Wang, S. Automated quantification of measurable residual disease in chronic lymphocytic leukemia using an artificial intelligence-assisted workflow. Cytometry Part B - Clinical Cytometry 106(4):264-271, 2024. e-Pub 2024. PMID: 36824056.
43. Fang H, Wang SA, Beird HC, Tang Z, You M, Li S, Xu J, Hu S, Yin C, Hussein SE, Lin P, Jelloul FZ, Vega F, Medeiros L, Wang W. Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia, 2024. PMID: 38946194.
44. Yin, CC, Tam, W, Walker, SM, Kaur, A, Ouseph, MM, Xie, W, Weinberg, OK, Li, P, Zuo, Z, Routbort, MJ, Chen, S, Medeiros, LJ, George, T, Orazi, A, Arber, DA, Bagg, A, Hasserjian, RP, Wang, S. STAT5B mutations in myeloid neoplasms differ by disease subtypes but characterize a subset of chronic myeloid neoplasms with eosinophilia and/or basophilia. Haematologica 109(6):1825-1826, 2024. e-Pub 2024. PMID: 37981812.
45. Jen, WY, Sasaki, K, Loghavi, S, Wang, S, Qiao, W, Borthakur, G, Ravandi-Kashani, F, Kadia, TM, Issa, GC, Short, NJ, Yilmaz, M, Daver, N, DiNardo, C. Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression. British Journal of Haematology 204(6):2259-2263, 2024. e-Pub 2024. PMID: 38603594.
46. Nwogbo, OV, Fang, H, Wang, W, Xu, J, Miranda, R, Bose, P, Ok, CY, Jorgensen, JL, Medeiros, LJ, Wang, S. Multicolor flow cytometric immunophenotyping is highly sensitive and specific in identifying aberrant mast cells in the diagnostic workup of systemic mastocytosis. American journal of clinical pathology 161(6):598-608, 2024. e-Pub 2024. PMID: 38372648.
47. Wei Q, Wang SA, Loghavi S, Fang H, Medeiros L, Wang W. Diagnostic utility of immunohistochemistry in detection of NPM1 mutations in acute myeloid leukemia with a patchy distribution, 2024. PMID: 38633114.
48. Jabbour E, Haddad FG, Short NJ, Senapati J, Jain N, Sasaki K, Jorgensen J, Wang SA, Alvarado Y, Wang X, DiNardo C, Masarova L, Kadia T, Garris RS, Ravandi F, Kantarjian H. Phase 2 study of inotuzumab ozogamicin for measurable residual disease in acute lymphoblastic leukemia in remission, 2024. PMID: 37879077.
49. Shuyu, E, Nahmod, KA, Wang, S, Yin, CC. Unique blast phase of chronic myeloid leukemia with concurrent erythroid and megakaryocytic differentiation. International Journal of Laboratory Hematology 46(1):5-7, 2024. e-Pub 2024. PMID: 37674279.
50. Zhou T, Curry CV, Khanlari M, Shi M, Cui W, Peker D, Chen W, Wang E, Gao J, Shen Q, Xie W, Jelloul FZ, King RL, Yuan J, Wang X, Zhao C, Obiorah IE, Courville EL, Nomura E, Cherian S, Xu ML, Burack W, Liu H, Jabbour EJ, Takahashi K, Wang W, Wang SA, Khoury JD, Medeiros L, Hu S. Genetics and pathologic landscape of lineage switch of acute leukemia during therapy, 2024. PMID: 38272888.
51. Hamilton, MJ, Greene, LW, Madigan, LM, Wang, S, Arana Yi, C, Kuykendall, A, George, T, Castells, M. Case Report. Frontiers in Allergy 5, 2024. e-Pub 2024. PMID: 39493747.
52. Gunther, J, Iyer, SP, Hunt, KK, Fang, H, Wang, S, Clemens, MW, Pinnix, CC. Beyond surgery. Case Reports in Plastic Surgery and Hand Surgery 11(1), 2024. e-Pub 2024. PMID: 39119029.
53. Kadia TM, Ravandi F, Molica M, Bataller A, Borthakur G, Daver N, Jabbour E, DiNardo CD, Pemmaraju N, Jain N, Ferrajoli A, Ylimaz M, Bose P, Tidwell RS, Marx KR, Rausch CR, Kanagal-Shamanna R, Wang S, Islam R, Champlin R, Shpall E, Konopleva M, Garcia-Manero G, Kantarjian H. Phase II study of cladribine, idarubicin, and ara-C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia, 2023. PMID: 37635400.
54. Wang SA, Jorgensen JL, Hu S, Jia F, Li S, Loghavi S, Ok CY, Thakral B, Xu J, Medeiros L, Wang W. Validation of a 12-color flow cytometry assay for acute myeloid leukemia minimal/measurable residual disease detection, 2023. PMID: 37605812.
55. Fang H, Beird HC, Wang SA, Ibrahim AF, Tang Z, Tang G, You M, Hu S, Xu J, Li S, Yin C, Hussein SE, Le N, Futreal P, Bueso-Ramos C, Thakral B, Kadia TM, Thornton R, Little L, Gumbs C, Song X, Medeiros L, Wang W. T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis, 2023. PMID: 37443196.
56. Jelloul FZ, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Thakral B, Zuo Z, Yin C, Loghavi S, Ok CY, Wang SA, Tang Z, You M, Patel KP, Medeiros L, Quesada AE. DDX41 mutations in patients with non-myeloid hematologic neoplasms. Am J Hematol, 2023. PMID: 37154083.
57. Kirtek, T, Chen, W, Laczko, D, Bagg, A, Koduru, P, Foucar, K, Venable, E, Nichols, MM, Rogers, HJ, Tam, W, Orazi, A, Hsi, ED, Hasserjian, RP, Wang, S, Arber, DA, Weinberg, OK. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype. Leukemia Research 130, 2023. e-Pub 2023. PMID: 37210875.
58. Wang SA, Bazinet A, Kadia T, Short NJ, Borthakur G, Wang SA, Wang W, Loghavi S, Jorgensen J, Patel K, DiNardo C, Daver N, Alvarado Y, Haddad FG, Pierce S, Gonzalez GN, Maiti A, Sasaki K, Yilmaz M, Thompson P, Wierda W, Garcia-Manero G, Andreeff M, Jabbour E, Konopleva M, Huang X, Kantarjian H, Ravandi F. Undetectable measurable residual disease is associated with improved outcomes in AML irrespective of treatment intensity, 2023. e-Pub 2023. PMID: 36884300.
59. Thompson PA, Keating MJ, Ferrajoli A, Jain N, Peterson CB, Garg N, Wang SA, Jorgensen JL, Kadia TM, Bose P, Pemmaraju N, Short NJ, Wierda WG. Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRD, 2023. PMID: 37138019.
60. Wang SA, Jabbour E, Short NJ, Senapati J, Jain N, Huang X, Daver N, DiNardo CD, Pemmaraju N, Wierda W, Garcia-Manero G, Bravo GM, Sasaki K, Kadia TM, Khoury J, Wang SA, Haddad FG, Jacob J, Garris R, Ravandi F, Kantarjian HM. Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial, 2023. PMID: 37187201.
61. Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros L, Xu J. DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma, 2023. PMID: 36453104.
62. Desikan SP, Senapati J, Jabbour E, Abuasab T, Short N, Tang G, Wang S, Kebriaei P, Kadia T, Borthakur G, Ravandi F, Roberts K, Mullighan C, Konopleva M, Kantarjian H, Jain N. Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia, 2023. PMID: 36877196.
63. Siddiqui M, Konoplev S, Issa G, Kantarjian H, Daver N, Ravandi F, Kadia T, Tang G, Wang SA, Thakral B, Medeiros L, Pozdnyakova O, Pierce S, Montalban-Bravo G, Chien K, Hammond D, Sasaki K, Garcia-Manero G, Hasserjian RP. Biologic features and clinical outcomes in newly diagnosed myelodysplastic syndrome with KMT2A rearrangements, 2023. PMID: 36661399.
64. Al-Ghamdi YA, Lake J, Bagg A, Thakral B, Wang SA, Bueso-Ramos C, Masarova L, Verstovsek S, Rogers HJ, Hsi ED, Gralewski JH, Chabot-Richards D, George TI, Rets A, Hasserjian RP, Weinberg OK, Parilla M, Arber DA, Padilla O, Orazi A, Tam W. Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study, 2023. PMID: 36788093.
65. Qiu, L, Wang, S, Tang, G, Wang, W, Lin, P, Xu, J, Yin, CC, Khanlari, M, Medeiros, LJ, Li, S. Blastoid B-Cell Neoplasms. Cancers 15(3), 2023. e-Pub 2023. PMID: 36765805.
66. Cantu, MD, Kanagal-Shamanna, R, Wang, S, Kadia, TM, Bueso-Ramos, CE, Patel, S, Geyer, JT, Tam, W, Madanat, Y, Li, P, George, T, Nichols, MM, Rogers, HJ, Liu, YC, Aggarwal, N, Kurzer, JH, Maracaja, DL, Hsi, ED, Zaiem, F, Babu, D, Foucar, K, Laczko, D, Bagg, A, Orazi, A, Arber, DA, Hasserjian, RP, Weinberg, OK. Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia. JCO Precision Oncology 7, 2023. e-Pub 2023. PMID: 36689697.
67. Aakash, FN, Wang, S, Saluja, K, Thakral, B. Persistent polyclonal B-cell lymphocytosis with buttock-like cells mimicking follicular lymphoma. Blood Research 58(3):125, 2023. e-Pub 2023. PMID: 37482695.
68. Short NJ, Macaron W, Kadia T, Dinardo C, Issa GC, Daver N, Wang SA, Jorgensen J, Nguyen D, Bidikian A, Patel KP, Loghavi S, Konopleva M, Yilmaz M, Jabbour E, Maiti A, Abbas HA, Shpall E, Popat U, Al-Atrash G, Pierce S, Kantarjian HM, Ravandi F. Clinical outcomes and impact of therapeutic intervention in patients with acute myeloid leukemia who experience measurable residual disease (MRD) recurrence following MRD-negative remission. Am J Hematol 97(11):E408-E411, 2022. e-Pub 2022. PMID: 36054774.
69. Fang H, Wang SA, You MJ, Hu S, Miranda RN, Tang Z, Lin P, Jorgensen JL, Xu J, Thakral B, Schlette EJ, El Hussein S, Bueso-Ramos C, Medeiros LJ, Wang W. Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors. Cytometry B Clin Cytom 102(6):440-447, 2022. e-Pub 2022. PMID: 36156384.
70. Tashakori M, Khoury JD, Routbort MJ, Patel KP, Wang SA, Ok CY, El-Hussein S, Kanagal-Shamanna R, Luthra R, Hu S, Lin P, Pemmaraju N, Bose P, Verstovsek S, Bueso-Ramos CE, Medeiros LJ, Loghavi S. Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations. Mod Pathol 35(11):1677-1683, 2022. e-Pub 2022. PMID: 35690645.
71. Qiu L, Xu J, Lin P, Cohen EN, Tang G, Wang SA, Khanlari M, Wang W, Khoury JD, Konoplev S, Yin CC, Jorgensen JL, Vega F, Medeiros LJ, Li S. Unique pathologic features and gene expression signatures distinguish blastoid high-grade B-cell lymphoma from B acute lymphoblastic leukemia/lymphoma. Haematologica, 2022. e-Pub 2022. PMID: 36325892.
72. Jabbour EJ, Short NJ, Jain N, Jammal N, Jorgensen J, Wang S, Wang X, Ohanian M, Alvarado Y, Kadia T, Sasaki K, Garris R, Garcia-Manero G, Ravandi F, Kantarjian HM. Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10-4 and higher. Am J Hematol 97(9):1135-1141, 2022. e-Pub 2022. PMID: 35713551.
73. Fang H, Wang SA, Khoury JD, El Hussein S, Kim DH, Tashakori M, Tang Z, Li S, Hu Z, Jelloul FZ, Patel KP, McDonnell TJ, Kadia T, Medeiros LJ, Wang W. Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases. Haematologica 107(9):2232-2237, 2022. e-Pub 2022. PMID: 35511670.
74. Kaumeyer BA, Fidai SS, Thakral B, Wang SA, Arber DA, Cheng JX, Gurbuxani S, Venkataraman G. GLUT1 Immunohistochemistry Is a Highly Sensitive and Relatively Specific Marker for Erythroid Lineage in Benign and Malignant Hematopoietic Tissues. Am J Clin Pathol 158(2):228-234, 2022. e-Pub 2022. PMID: 35311938.
75. DiNardo CD, Lachowiez CA, Takahashi K, Loghavi S, Kadia T, Daver N, Xiao L, Adeoti M, Short NJ, Sasaki K, Wang SA, Borthakur G, Issa G, Maiti A, Alvarado Y, Pemmaraju N, Bravo GM, Masarova L, Yilmaz M, Jain N, Andreeff M, Garcia-Manero G, Kornblau S, Ravandi F, Jabbour E, Konopleva MY, Kantarjian HM. Venetoclax combined with FLAG-IDA induction and consolidation in newly diagnosed acute myeloid leukemia. Am J Hematol 97(8):1035-1043, 2022. e-Pub 2022. PMID: 35583199.
76. Short NJ, Kantarjian H, Ravandi F, Konopleva M, Jain N, Kanagal-Shamanna R, Patel KP, Macaron W, Kadia TM, Wang S, Jorgensen JL, Khoury JD, Yilmaz M, Kebriaei P, Takahashi K, Garcia-Manero G, Daver N, Post SM, Huang X, Kornblau SM, Pelletier S, Flores W, Matthews J, Garris R, Jabbour E. High-sensitivity next-generation sequencing MRD assessment in ALL identifies patients at very low risk of relapse. Blood Adv 6(13):4006-4014, 2022. e-Pub 2022. PMID: 35533262.
77. Wang W, Xu J, Khoury JD, Pemmaraju N, Fang H, Miranda RN, Yin CC, Hussein SE, Jia F, Tang Z, Hu S, Konopleva M, Medeiros LJ, Wang SA. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel) 14(14), 2022. e-Pub 2022. PMID: 35884435.
78. Qiu L, Nunez CA, Tang G, Cuglievan B, Issa GC, Wang SA, Medeiros LJ, Thakral B. A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusion. Ann Hematol 101(7):1579-1581, 2022. e-Pub 2022. PMID: 35091795.
79. Tashakori M, Wang W, Kadia TM, Daver NG, Montalban-Bravo G, Loghavi S, Wang SA, Medeiros LJ, Ravandi F, Khoury JD. Differential characteristics of TP53 alterations in pure erythroid leukemia arising after exposure to cytotoxic therapy. Leuk Res 118:106860, 2022. e-Pub 2022. PMID: 35636055.
80. Fang H, Wang SA, Hu S, Konoplev SN, Mo H, Liu W, Zuo Z, Xu J, Jorgensen JL, Yin CC, El Hussein S, Jelloul FZ, Tang Z, Medeiros LJ, Wang W. Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometry. Cytometry B Clin Cytom 102(4):283-291, 2022. e-Pub 2022. PMID: 35716019.
81. Qiu L, Wang SA, Vega F, Khoury JD, Tang Z, Garces S, Medeiros LJ, Thakral B. From the archives of MD Anderson Cancer Center: Intravascular large B-cell lymphoma with numerous circulating lymphoma cells. Ann Diagn Pathol 58:151934, 2022. e-Pub 2022. PMID: 35299081.
82. Yilmaz M, Kantarjian H, Short NJ, Reville P, Konopleva M, Kadia T, DiNardo C, Borthakur G, Pemmaraju N, Maiti A, Jabbour E, Jain N, Issa G, Takahashi K, Sasaki K, Ohanian M, Pierce S, Tang G, Loghavi S, Patel K, Wang SA, Garcia-Manero G, Andreeff M, Ravandi F, Daver N. Hypomethylating agent and venetoclax with FLT3 inhibitor "triplet" therapy in older/unfit patients with FLT3 mutated AML. Blood Cancer J 12(5):77, 2022. e-Pub 2022. PMID: 35501304.
83. Khanlari M, Yin CC, Takahashi K, Lachowiez C, Tang G, Loghavi S, Bah I, Wang W, Konoplev S, Medeiros LJ, Pemmaraju N, Khoury JD, Wang SA. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients. Leukemia 36(5):1343-1350, 2022. e-Pub 2022. PMID: 35279700.
84. Chen MM, Roufosse F, Wang SA, Verstovsek S, Durrani SR, Rothenberg ME, Pongdee T, Butterfield J, Lax T, Wechsler ME, Stein ML, Ogbogu PU, Kahwash BM, Mathur SK, Simon D, Akuthota P, Holland N, Wetzler L, Ware JM, Guo C, Fay MP, Khoury P, Klion AD, Bochner BS. An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes. J Allergy Clin Immunol Pract 10(5):1217-1228.e3, 2022. e-Pub 2022. PMID: 35181548.
85. Kanagal-Shamanna R, Orazi A, Hasserjian RP, Arber DA, Reichard K, Hsi ED, Bagg A, Rogers HJ, Geyer J, Darbaniyan F, Do KA, Devins KM, Pozdnyakova O, George TI, Cin PD, Greipp PT, Routbort MJ, Patel K, Garcia-Manero G, Verstovsek S, Medeiros LJ, Wang SA, Bueso-Ramos C. Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group. Mod Pathol 35(5):705, 2022. e-Pub 2022. PMID: 34903824.
86. Kanagal-Shamanna R, Orazi A, Hasserjian RP, Arber DA, Reichard K, Hsi ED, Bagg A, Rogers HJ, Geyer J, Darbaniyan F, Do KA, Devins KM, Pozdnyakova O, George TI, Cin PD, Greipp PT, Routbort MJ, Patel K, Garcia-Manero G, Verstovsek S, Medeiros LJ, Wang SA, Bueso-Ramos C. Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group. Mod Pathol 35(4):470-479, 2022. e-Pub 2021. PMID: 34775472.
87. Zhao M, Medeiros LJ, Wang W, Tang G, Jung HS, Sfamenos SM, Fang H, Toruner GA, Hu S, Yin CC, Lin P, Gu J, Peng G, You MJ, Khoury JD, Wang SA, Tang Z. Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies. Cancer Genet 262-263:23-29, 2022. e-Pub 2022. PMID: 34974290.
88. Tang G, Zou Y, Wang SA, Borthakur G, Toruner G, Hu S, Li S, Xu J, Medeiros LJ, Tang Z. 3'CBFB deletion in CBFB-rearranged acute myeloid leukemia retains morphological features associated with inv(16), but patients have higher risk of relapse and may require stem cell transplant. Ann Hematol 101(4):847-854, 2022. e-Pub 2022. PMID: 35184217.
89. El Hussein S, DiNardo CD, Takahashi K, Khoury JD, Fang H, Furudate K, Lyapichev KA, Garces S, Kanagal-Shamanna R, Ok CY, Patel KP, Routbort MJ, Ravandi F, Medeiros LJ, Wang SA, Loghavi S. Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 57(3):370-376, 2022. e-Pub 2022. PMID: 34992253.
90. Wang ML, Jain P, Zhao S, Lee HJ, Nastoupil L, Fayad L, Ok CY, Kanagal-Shamanna R, Hill HA, Yao Y, Hagemeister FB, Westin JR, Fowler N, Samaniego F, Steiner R, Nair R, Iyer SP, Navsaria L, Badillo M, Research Group MC, Feng L, Xuelin H, Nogueras Gonzalez GM, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Lin P, Wang SA, Jorgensen J, Yin CC, Li S, Patel KP, Vega F, Medeiros LJ, Flowers CR, Wang L. Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (=65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial. Lancet Oncol 23(3):406-415, 2022. e-Pub 2022. PMID: 35074072.
91. Konoplev S, Wang X, Tang G, Li S, Wang W, Xu J, Pierce SA, Jia F, Jorgensen JL, Ravandi F, Issa GC, Medeiros LJ, Wang SA. Comprehensive immunophenotypic study of acute myeloid leukemia with KMT2A (MLL) rearrangement in adults: A single-institution experience. Cytometry B Clin Cytom 102(2):123-133, 2022. e-Pub 2022. PMID: 34964255.
92. Khanlari M, Wang X, Loghavi S, Wang SA, Li S, Thakral B, Bueso-Ramos CE, Yin CC, Kanagal-Shamanna R, Khoury JD, Patel KP, Popat UR, Medeiros LJ, Konoplev S. Value and pitfalls of assessing bone marrow morphologic findings to predict response in patients with myelofibrosis who undergo hematopoietic stem cell transplantation. Ann Diagn Pathol 56:151860, 2022. e-Pub 2022. PMID: 34823075.
93. El Hussein, S, Hu, S, Fang, H, Garces, S, Muzzafar, T, Wang, S, Medeiros, LJ, Bueso-Ramos, CE, Jelloul, FZ. Well-differentiated systemic mastocytosis with associated myeloid sarcoma and myelodysplastic syndrome. Leukemia and Lymphoma 63(1):235-238, 2022. e-Pub 2022. PMID: 34510998.
94. Qiu L, Xu J, Tang G, Wang SA, Lin P, Ok CY, Garces S, Yin CC, Khanlari M, Vega F, Medeiros LJ, Li S. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall. Hum Pathol 119:59-68, 2022. e-Pub 2021. PMID: 34767860.
95. Qiu L, Medeiros LJ, Tang G, Khanlari M, Li S, Konoplev S, Wang SA, Yin CC, Khoury JD, Wang W, Miranda RN, Iyer S, You MJ, Xu J. The Leukemic Phase of ALK-Negative Anaplastic Large Cell Lymphoma Is Associated with CD7 Positivity, Complex Karyotype, TP53 Deletion, and a Poor Prognosis. Cancers (Basel) 13(24), 2021. e-Pub 2021. PMID: 34944936.
96. Jain N, Thompson P, Burger J, Ferrajoli A, Takahashi K, Estrov Z, Borthakur G, Bose P, Kadia T, Pemmaraju N, Sasaki K, Konopleva M, Jabbour E, Garg N, Wang X, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang S, Lopez W, Ayala A, Plunkett W, Gandhi V, Kantarjian H, O'Brien S, Keating M, Wierda WG. Ibrutinib, fludarabine, cyclophosphamide, and obinutuzumab (iFCG) regimen for chronic lymphocytic leukemia (CLL) with mutated IGHV and without TP53 aberrations. Leukemia 35(12):3421-3429, 2021. e-Pub 2021. PMID: 34007049.
97. Morita, K, Wang, F, Jahn, K, Hu, T, Tanaka, T, Sasaki, Y, Kuipers, J, Loghavi, S, Wang, S, Yan, Y, Furudate, K, Matthews, JA, Little, L, Gumbs, C, Zhang, J, Song, X, Thompson, EJ, Patel, KP, Bueso-Ramos, CE, DiNardo, C, Ravandi-Kashani, F, Jabbour, EJ, Andreeff, M, Cortes, JE, Bhalla, K, Garcia-Manero, G, Kantarjian, HM, Konopleva, M, Nakada, D, Navin, N, Beerenwinkel, N, Futreal, A, Takahashi, K. Author Correction. Nature communications 12(1), 2021. e-Pub 2021. PMID: 33972555.
98. Mehta RS, Saliba RM, Alsfeld LC, Jorgensen JL, Wang SA, Anderlini P, Al-Atrash G, Bashir Q, Ciurea SO, Hosing CM, Im JS, Kebriaei P, Khouri I, Marin D, Nieto Y, Olson A, Oran B, Popat UR, Qazilbash MH, Ramdial J, Rondon G, Saini N, Srour SA, Rezvani K, Shpall EJ, Champlin RE, Alousi AM. Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide. Transplantation and Cellular Therapy 27(12):1003.e1-1003.e13, 2021. e-Pub 2021. PMID: 34537419.
99. El Hussein S, Wang W, Wang SA, Fang H, Garces S, Tashakori M, Lyapichev KA, Qiu L, Wang X, Loghavi S, Medeiros LJ, Challagundla P, Jorgensen JL. Hematogones with light chain restriction: A potential diagnostic pitfall when using flow cytometry analysis to assess bone marrow specimens. Leukemia Research 111:106704, 2021. e-Pub 2021. PMID: 34735934.
100. Tanaka T, Morita K, Wang F, Loghavi S, Furudate K, Sasaki Y, Little LD, Gumbs CE, Matthews J, Daver NG, Pemmaraju N, DiNardo CD, Sasaki K, Yilmaz M, Kadia TM, Ravandi F, Konopleva MY, Kantarjian HM, Champlin RE, Al-Atrash G, Garcia-Manero G, Wang SA, Futreal A, Takahashi K. Clonal Dynamics and clinical implications of Post-Remission Clonal Hematopoiesis in Acute Myeloid Leukemia (AML). Blood 138(18):1733-1739, 2021. e-Pub 2021. PMID: 34115096.
101. Wang SA, Chi Young OK, Kim AS, Lucas F, Morgan EA, Thakral B, Patel S, Nardi V, Patel KM, Weinberg OK, Hasserjian RP. Myelodysplastic Syndromes with No Somatic Mutations Detected by Next-Generation Sequencing Display Similar Features to Myelodysplastic Syndromes with Detectable Mutations. American journal of hematology 96(11):E420-E423, 2021. e-Pub 2021. PMID: 34416041.
102. Qiu L, Tang G, Li S, Wang W, Wang SA, Xu J. Blast phase of chronic myeloid leukemia presenting as early T-cell precursor lymphoblastic leukemia. EJHaem 2(4):895-896, 2021. e-Pub 2021. PMID: 35845203.
103. Yang RK, Toruner GA, Wang W, Fang H, Issa GC, Wang L, Quesada AE, Thakral B, Patel KP, Peng G, Liu S, Yin CC, Borthakur G, Tang Z, Wang SA, Miranda RN, Khoury JD, Medeiros LJ, Tang G. CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management. Cancers (Basel) 13(21), 2021. e-Pub 2021. PMID: 34771519.
104. Saxena K, Herbrich SM, Pemmaraju N, Kadia TM, DiNardo CD, Borthakur G, Pierce SA, Jabbour E, Wang SA, Bueso-Ramos C, Loghavi S, Tang G, Cheung CM, Alexander L, Kornblau S, Andreeff M, Garcia-Manero G, Ravandi F, Konopleva MY, Daver N. A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia. Cancer 127(20):3761-3771, 2021. e-Pub 2021. PMID: 34171128.
105. Sasaki K, Kantarjian HM, Morita K, Short NJ, Konopleva M, Jain N, Ravandi F, Garcia-Manero G, Wang S, Khoury JD, Jorgensen JL, Champlin RE, Khouri IF, Kebriaei P, Schroeder HM, Khouri M, Garris R, Takahashi K, O'Brien SM, Jabbour EJ. Hyper-CVAD plus ofatumumab versus hyper-CVAD plus rituximab as frontline therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: A propensity score analysis. Cancer 127(18):3381-3389, 2021. e-Pub 2021. PMID: 34138471.
106. Fang H, Wang W, Kadia TM, El Hussein S, Wang SA, Khoury JD. CD94 expression patterns in reactive and neoplastic T-cell and NK-cell proliferations. Leukemia Research 108:106614, 2021. e-Pub 2021. PMID: 33990003.
107. Tang G, Tam W, Short NJ, Bose P, Wu D, Hurwitz SN, Bagg A, Rogers HJ, Hsi ED, Quesada AE, Wang W, Miranda RN, Bueso-Ramos CE, Medeiros LJ, Nardi V, Hasserjian RP, Arber DA, Orazi A, Foucar K, Wang SA. Myeloid/lymphoid neoplasms with FLT3 rearrangement. Modern Pathology 34(9):1673-1685, 2021. e-Pub 2021. PMID: 33990705.
108. DiNardo CD, Lachowiez CA, Takahashi K, Loghavi S, Xiao L, Kadia T, Daver N, Adeoti M, Short NJ, Sasaki K, Wang S, Borthakur G, Issa G, Maiti A, Alvarado Y, Pemmaraju N, Montalban Bravo G, Masarova L, Yilmaz M, Jain N, Andreeff M, Jabbour E, Garcia-Manero G, Kornblau S, Ravandi F, Konopleva MY, Kantarjian HM. Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. Journal of Clinical Oncology 39(25):2768-2778, 2021. e-Pub 2021. PMID: 34043428.
109. Jain N, Keating M, Thompson P, Ferrajoli A, Burger JA, Borthakur G, Takahashi K, Estrov Z, Sasaki K, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang SA, Garg N, Wang X, Wei C, Cruz N, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda WG. Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial. JAMA Oncology 7(8):1213-1219, 2021. e-Pub 2021. PMID: 34110383.
110. Kadia TM, Reville PK, Borthakur G, Yilmaz M, Kornblau S, Alvarado Y, Dinardo CD, Daver N, Jain N, Pemmaraju N, Short N, Wang SA, Tidwell RSS, Islam R, Konopleva M, Garcia-Manero G, Ravandi F, Kantarjian HM. Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial. The Lancet Haematology 8(8):e552-e561, 2021. e-Pub 2021. PMID: 34329576.
111. Thakral B, Jain N, Tang G, Konoplev S, Vega F, Medeiros LJ, Wang SA. From the archives of MD Anderson Cancer Center. Annals of Diagnostic Pathology 53:151767, 2021. e-Pub 2021. PMID: 34118580.
112. Weinberg OK, Chisholm KM, Ok CY, Fedoriw Y, Grzywacz B, Kurzer JH, Mason EF, Moser KA, Bhattacharya S, Xu M, Babu D, Foucar K, Tam W, Bagg A, Orazi A, George TI, Wang W, Wang SA, Arber DA, Hasserjian RP. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group. Modern Pathology 34(7):1358-1366, 2021. e-Pub 2021. PMID: 33526873.
113. Koller P, Saliba RM, Ledesma C, Rondon G, Popat U, Alousi A, Mehta R, Oran B, Olson A, Hosing C, Qazilbash M, Khouri I, Ciurea S, Shpall E, Jorgensen J, Wang S, Jain N, Jabbour E, Kantarjian H, Champlin R, Konopleva M, Kebriaei P. Outcomes in patients with CRLF2 overexpressed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation. Bone marrow transplantation 56(7):1746-1749, 2021. e-Pub 2021. PMID: 33767403.
114. Fang H, Wang SA, Xie W, Tang Z, Hu S, Krishnamurthy S, Medeiros LJ, Wang W. Clinicopathologic Features of Myelodysplastic Syndromes Involving Lymph Nodes. Am J Surg Pathol 45(7):930-938, 2021. e-Pub 2021. PMID: 33739784.
115. Khanlari M, Wang SA, Fowler NH, Tang G, Saluja K, Muzzafar T, Medeiros LJ, Thakral B. Concurrent TP53 Mutation and Deletion in Refractory Low-grade Follicular Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 21(7):e626-e629, 2021. e-Pub 2021. PMID: 33867306.
116. Abou Dalle I, Kantarjian HM, Ravandi F, Daver N, Wang X, Jabbour E, Estrov Z, DiNardo CD, Pemmaraju N, Ferrajoli A, Jain N, Wang SA, Jammal N, Borthakur G, Naqvi K, Pelletier S, Pierce S, Andreeff M, Garcia-Manero G, Cortes JE, Kadia TM. Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission. Cancer 127(11):1894-1900, 2021. e-Pub 2021. PMID: 33449377.
117. Hu Z, Wang W, Thakral B, Chen Z, Estrov Z, Bueso-Ramos CE, Verstovsek S, Medeiros LJ, Wang SA. Lymphocytic variant of hypereosinophilic syndrome. Cytometry Part B - Clinical Cytometry 100(3):352-360, 2021. e-Pub 2021. PMID: 32157815.
118. El Hussein S, Khoury JD, Lyapichev KA, Tashakori M, Khanlari M, Miranda RN, Kanagal-Shamanna R, Wang SA, Ahmed A, Mirza KM, Crane GM, Medeiros LJ, Loghavi S. Next-Generation Scholarship: Rebranding Hematopathology Using Twitter: The MD Anderson Experience. Mod Pathol 34(5):854-861, 2021. e-Pub 2021. PMID: 33219298.
119. Wang W, Khoury JD, Miranda RN, Jorgensen JL, Xu J, Loghavi S, Li S, Pemmaraju N, Nguyen T, Medeiros LJ, Wang SA. Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm. Haematologica 106(4):1047-1055, 2021. e-Pub 2021. PMID: 32241840.
120. Lyapichev KA, Sukswai N, Angelova E, Kersh MJ, Pierce S, Konopleva M, Jain N, Jabbour EJ, Jorgensen JL, Wang SA, Medeiros LJ, Khoury JD, Konoplev S. CD123 Expression in Philadelphia Chromosome-like B Acute Lymphoblastic Leukemia/Lymphoma. Clin Lymphoma Myeloma Leuk 21(4):e317-e320, 2021. e-Pub 2021. PMID: 33129747.
121. Loghavi S, DiNardo CD, Furudate K, Takahashi K, Tanaka T, Short NJ, Kadia T, Konopleva M, Kanagal-Shamanna R, Farnoud NR, Pierce S, Khoury JD, Jorgensen JL, Patel KP, Daver N, Yilmaz M, Medeiros LJ, Kantarjian H, Ravandi F, Wang SA. Flow cytometric immunophenotypic alterations of persistent clonal haematopoiesis in remission bone marrows of patients with NPM1-mutated acute myeloid leukaemia. British Journal of Haematology 192(6):1054-1063, 2021. e-Pub 2021. PMID: 33618432.
122. Maiti A, Rausch CR, Cortes JE, Pemmaraju N, Daver NG, Ravandi F, Garcia-Manero G, Borthakur G, Naqvi K, Ohanian M, Short NJ, Alvarado Y, Kadia TM, Takahashi K, Yilmaz M, Jain N, Kornblau S, Montalban Bravo G, Sasaki K, Andreeff M, Bose P, Ferrajoli A, Issa GC, Jabbour EJ, Masarova L, Thompson PA, Wang SA, Konoplev S, Pierce SA, Ning J, Qiao W, Welch JS, Kantarjian HM, DiNardo CD, Konopleva MY. Outcomes of relapsed or refractory acute myeloid leukemia after front-line hypomethylating agent and venetoclax regimens. Haematologica 106(3):894-898, 2021. e-Pub 2021. PMID: 32499238.
123. Lyapichev KA, Bah I, Huen A, Duvic M, Routbort MJ, Wang W, Jorgensen JL, Medeiros LJ, Vega F, Craig FE, Wang SA. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells. Cytometry Part B - Clinical Cytometry 100(2):183-191, 2021. e-Pub 2021. PMID: 32667737.
124. Alotaibi AS, Yilmaz M, Kanagal-Shamanna R, Loghavi S, Kadia TM, DiNardo CD, Borthakur G, Konopleva M, Pierce SA, Wang SA, Tang G, Guerra V, Samra B, Pemmaraju N, Jabbour E, Short NJ, Issa GC, Ohanian M, Garcia-Manero G, Bhalla KN, Patel KP, Takahashi K, Andreeff M, Cortes JE, Kantarjian HM, Ravandi F, Daver N. Patterns of Resistance Differ in Patients with Acute Myeloid Leukemia Treated with Type I versus Type II FLT3 inhibitors. Blood Cancer Discov 2(2):125-134, 2021. e-Pub 2021. PMID: 33681815.
125. Kelemen K, Saft L, Craig FE, Orazi A, Nakashima M, Wertheim GB, George TI, Horny HP, King RL, Quintanilla-Martinez L, Wang SA, Rimsza LM, Reichard KK. Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders. American journal of clinical pathology 155(2):179-210, 2021. e-Pub 2021. PMID: 33367563.
126. Maiti A, DiNardo CD, Wang SA, Jorgensen J, Kadia TM, Daver NG, Short NJ, Yilmaz M, Pemmaraju N, Borthakur G, Bose P, Issa GC, Ferrajoli A, Jabbour EJ, Jain N, Garcia-Manero G, Ohanian M, Takahashi K, Montalban-Bravo G, Masarova L, Burger JA, Thompson PA, Verstovsek S, Sasaki K, Andreeff M, Rausch CR, Montalbano KS, Pierce S, Qiao W, Ning J, Kantarjian HM, Konopleva MY, Ravandi F. Prognostic value of measurable residual disease after venetoclax and decitabine in acute myeloid leukemia. Blood Advances 5(7):1876-1883, 2021. e-Pub 2021. PMID: 33792630.
127. Ok CY, Trowell KT, Parker KG, Moser K, Weinberg OK, Rogers HJ, Reichard KK, George TI, Hsi ED, Bueso-Ramos CE, Tam W, Orazi A, Bagg A, Arber DA, Hasserjian RP, Wang SA. Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1. Modern Pathology 34(1):20-31, 2021. e-Pub 2021. PMID: 32694616.
128. Short NJ, Rafei H, Daver N, Hwang H, Ning J, Jorgensen JL, Kadia TM, DiNardo CD, Wang SA, Jabbour E, Popat U, Oran B, Cortes J, Konopleva M, Yilmaz M, Issa GC, Kantarjian H, Ravandi F. Prognostic impact of complete remission with MRD negativity in patients with relapsed or refractory AML. Blood Advances 4(24):6117-6126, 2020. e-Pub 2020. PMID: 33351107.
129. Morita, K, Wang, F, Jahn, K, Hu, T, Tanaka, T, Sasaki, Y, Kuipers, J, Loghavi, S, Wang, S, Yan, Y, Furudate, K, Matthews, JA, Little, L, Gumbs, C, Zhang, J, Song, X, Thompson, EJ, Patel, KP, Bueso-Ramos, CE, DiNardo, C, Ravandi-Kashani, F, Jabbour, EJ, Andreeff, M, Cortes, JE, Bhalla, K, Garcia-Manero, G, Kantarjian, HM, Konopleva, M, Nakada, D, Navin, N, Beerenwinkel, N, Futreal, A, Takahashi, K. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nature communications 11(1), 2020. e-Pub 2020. PMID: 33087716.
130. Chen Z, Hu S, Wang SA, Konopleva M, Tang Z, Xu J, Li S, Toruner G, Thakral B, Medeiros LJ, Tang G. Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia. Leukemia and Lymphoma 61(12):2831-2838, 2020. e-Pub 2020. PMID: 32700989.
131. DiNardo CD, Maiti A, Rausch CR, Pemmaraju N, Naqvi K, Daver NG, Kadia TM, Borthakur G, Ohanian M, Alvarado Y, Issa GC, Montalban-Bravo G, Short NJ, Yilmaz M, Bose P, Jabbour EJ, Takahashi K, Burger JA, Garcia-Manero G, Jain N, Kornblau SM, Thompson PA, Estrov Z, Masarova L, Sasaki K, Verstovsek S, Ferrajoli A, Weirda WG, Wang SA, Konoplev S, Chen Z, Pierce SA, Ning J, Qiao W, Ravandi F, Andreeff M, Welch JS, Kantarjian HM, Konopleva MY. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia. The Lancet Haematology 7(10):e724-e736, 2020. e-Pub 2020. PMID: 32896301.
132. Tang Z, Toruner GA, Tang G, Yin CC, Wang W, Hu S, Thakral B, Wang SA, Miranda RN, Khoury JD, Medeiros LJ. Chronic myeloid leukemia with insertion-derived BCR-ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis. Modern Pathology 33(10):2088, 2020. e-Pub 2020. PMID: 32737448.
133. Tang Z, Toruner GA, Tang G, Cameron Yin C, Wang W, Hu S, Thakral B, Wang SA, Miranda RN, Khoury JD, Medeiros LJ. Chronic myeloid leukemia with insertion-derived BCR–ABL1 fusion. Modern Pathology 33(10):2035-2045, 2020. e-Pub 2020. PMID: 32404952.
134. Gupta SK, Jain N, Tang G, Futreal A, Wang SA, Khoury JD, Yang RK, Fang H, Patel KP, Luthra R, Routbort M, Barkoh BA, Chen W, Mao X, Zhang J, Medeiros LJ, Bueso-Ramos CE, Loghavi S. A cryptic BCR-PDGFRB fusion resulting in a chronic myeloid neoplasm with monocytosis and eosinophilia. JNCCN Journal of the National Comprehensive Cancer Network 18(10):1300-1304, 2020. e-Pub 2020. PMID: 33022638.
135. Foucar K, Hsi ED, Wang SA, Rogers HJ, Hasserjian RP, Bagg A, George TI, Bassett RL, Peterson LC, Morice WG, Arber DA, Orazi A, Bueso-Ramos CE, Pathology Group BM. Concordance among hematopathologists in classifying blasts plus promonocytes. International Journal of Laboratory Hematology 42(4):418-422, 2020. e-Pub 2020. PMID: 32297416.
136. 231Khanlari M, Wang SA, Tang G, Saluja K, Medeiros LJ, Thakral B. CD45-negative follicular lymphoma: A rare diagnostic pitfall of a common entity. Cytometry B Clin Cytom, 2020. e-Pub 2020.
137. Jabbour E, Richard-Carpentier G, Sasaki Y, Konopleva M, Patel K, Roberts K, Gu Z, Wang F, Huang X, Sasaki K, Short NJ, Jain N, Ravandi F, Daver NG, Kadia TM, Alvarado Y, DiNardo CD, Issa GC, Pemmaraju N, Garcia-Manero G, Verstovsek S, Wang SA, Khoury JD, Jorgensen J, Champlin R, Khouri I, Kebriaei P, Schroeder H, Khouri M, Mullighan CG, Takahashi K, O'Brien SM, Kantarjian H. Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial. The Lancet Haematology 7(7):e523-e533, 2020. e-Pub 2020. PMID: 32589978.
138. Sasaki K, Kantarjian H, Wierda W, Ravandi-Kashani F, Jorgensen J, Wang SA, Khoury J, Daver N, Burger J, Di Nardo CD, Jain N, Short NJ, Estrov Md Z, Konopleva Md PhD M, Ohanian DO M, Garcia-Manero G, Kadia T, Alvarado-Valero Y, Yilmaz M, Pierce S, Garris R, Ingram A, Cortes J, O'Brien S, Jabbour E. Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia. American journal of hematology 95(7):734-739, 2020. e-Pub 2020. PMID: 32170867.
139. Rogers HJ, Wang X, Xie Y, Davis AR, Thakral B, Wang SA, Borthakur G, Cantu MD, Margolskee EM, Philip JKS, Sukhanova M, Bagg A, Bueso-Ramos CE, Orazi A, Arber DA, Hsi ED, Hasserjian RP. Comparison of therapy-related and de novo core binding factor acute myeloid leukemia. American journal of hematology 95(7):799-808, 2020. e-Pub 2020. PMID: 32249963.
140. Fang H, Tang G, Loghavi S, Greipp P, Wang W, Verstovsek S, Medeiros LJ, Reichard KK, Miranda RN, Wang SA. Systematic use of fluorescence in-situ hybridisation and clinicopathological features in the screening of PDGFRB rearrangements of patients with myeloid/lymphoid neoplasms. Histopathology 76(7):1042-1055, 2020. e-Pub 2020. PMID: 32083752.
141. Shen J, Medeiros LJ, Li S, Wang SA, Lin P, Khanlari M, Iyer SP, Yin CC, Tang G, Jorgensen JL, Hu S, Miranda RN, Xu J. CD8 expression in anaplastic large cell lymphoma correlates with noncommon morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative anaplastic large cell lymphoma. Human Pathology 98:1-9, 2020. e-Pub 2020. PMID: 32032618.
142. Ye MT, Wang Y, Wang SA, Pemmaraju N, Daver N, Verstovsek S, Zhang Y, Zuo Z, Medeiros LJ, You MJ. Concurrent JAK2 V617F and MPL W515L in myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. Leukemia and Lymphoma 61(4):963-966, 2020. e-Pub 2020. PMID: 31750750.
143. Shen J, Li S, Medeiros LJ, Lin P, Wang SA, Tang G, Yin CC, You MJ, Khoury JD, Iyer SP, Miranda RN, Xu J. PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. Modern Pathology 33(3):324-333, 2020. e-Pub 2020. PMID: 31383967.
144. Xie W, Tang G, Wang E, Kim Y, Cloe A, Shen Q, Zhou Y, Garcia-Manero G, Loghavi S, Hu AY, Wang SA, Bueso-Ramos CE, Kantarjian HM, Medeiros LJ, Hu S. t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?. Annals of Hematology 99(3):487-500, 2020. e-Pub 2020. PMID: 32006151.
145. Thakral B, Muzzafar T, Wang SA, Medeiros LJ. Myeloid neoplasm with eosinophilia and BCR-JAK2/t(9;22)(p24;q11.2) morphologically mimicking chronic myeloid leukemia. Ann Diagn Pathol 44:151405, 2020. e-Pub 2020. PMID: 31865248.
146. Sakhdari A, Thakral B, Loghavi S, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Luthra R, Medeiros LJ, Wang SA, Patel KP, Ok CY. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD. Cancer medicine 9(3):849-858, 2020. e-Pub 2020. PMID: 31804006.
147. Kongtim P, Hasan O, Perez JMR, Varma A, Wang SA, Patel KP, Chen J, Rondon G, Srour S, Bashir Q, Qazilbash M, Mehta R, Shpall EJ, Alousi A, Khouri I, Kebriaei P, Popat U, Champlin RR, Ciurea SO. Novel Disease Risk Model for Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 26(1):197-203, 2020. e-Pub 2020. PMID: 31518645.
148. Chen Z, Ok CY, Wang W, Goswami M, Tang G, Routbort M, Jorgensen JL, Medeiros LJ, Wang SA. Low-Grade Myelodysplastic Syndromes with Preserved CD34+ B-Cell Precursors (CD34+ Hematogones). Cytometry Part B - Clinical Cytometry 98(1):36-42, 2020. e-Pub 2020. PMID: 31211490.
149. Xie W, Chen Z, Wang SA, Hu S, Li S, Miranda RN, Medeiros LJ, Tang G. Lymphoblastic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Leuk Lymphoma 60(12):2993-3001, 2019. e-Pub 2019. PMID: 31017498.
150. Chen Z, Wang SA, Goswami M, Tang G, Routbort MJ, Patel KP, Luthra R, Medeiros LJ, Ok CY. Comparison of therapy-related myelodysplastic syndrome with ring sideroblasts and de novo myelodysplastic syndrome with ring sideroblasts. Leukemia Research 86:106227, 2019. e-Pub 2019. PMID: 31557598.
151. Jain N, Keating MJ, Thompson PA, Ferrajoli A, Burger JA, Borthakur GM, Takahashi K, Estrov ZE, Fowler NH, Kadia TM, Konopleva MY, Alvarado Y, Yilmaz M, DiNardo CD, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen JL, Wang SA, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian HM, Gandhi V, Wierda WG. Combined Ibrutinib and Venetoclax for First-Line Treatment for Patients with Chronic Lymphocytic Leukemia (CLL). Blood, 2019. e-Pub 2019. PMID: 31724006.
152. Tallis E, Loghavi S, Jorgensen JL, Wang S, Khoury JD, Bueso-Ramos CB, Jain N, Borthakur G, Pemmaraju N. Patient with mixed-phenotype acute leukemia with CBFB rearrangement. Leukemia and Lymphoma 60(11):2829-2831, 2019. e-Pub 2019. PMID: 31012358.
153. Sukswai, N, Aung, PP, Yin, CC, Li, S, Wang, W, Wang, S, Ortega, V, Lyapichev, KA, Nagarajan, P, Alfattal, R, Angelova, EA, Tang, Z, Loghavi, S, Kanagal Shamanna, R, Miranda, R, Pemmaraju, N, Bhalla, K, Konopleva, M, Medeiros, LJ, Khoury, J. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific for Blastic Plasmacytoid Dendritic Cell Neoplasm. American Journal of Surgical Pathology 43(10):1429-1437, 2019. e-Pub 2019. PMID: 31261288.
154. Salehi S, Astle JM, Sadigh S, Lake J, Aikawa V, Tang G, Wang SA, Bagg A. Myeloid neoplasm with eosinophilia and PCM1-JAK2 associated with acute promyelocytic leukemia with PML-RARA. Leukemia and Lymphoma 60(9):2299-2303, 2019. e-Pub 2019. PMID: 30806106.
155. Li N, Wang SA, Lin P, Jabbour E, Thompson P, Chen Z, Li S, Xu J, You MJ, Bueso-Ramos CE, Medeiros LJ, Yin CC. Relapsed B-acute lymphoblastic leukemia with aberrant myeloperoxidase expression following CAR T-cell therapy: A diagnostic challenge. American Journal of Hematology 94(9):1049-1051, 2019. e-Pub 2019. PMID: 30916805.
156. Weinberg OK, Hasserjian RP, Baraban E, Ok CY, Geyer JT, JKSS P, Kurzer JH, Rogers HJ, Nardi V, Stone RM, Garcia JS, Hsi ED, Bagg A, Wang SA, Orazi A, Arber DA. Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation. Mod Pathol 32(9):1373-1385, 2019. e-Pub 2019. PMID: 31000771.
157. Chen Z, Sun Y, Xie W, Wang SA, Hu S, Li S, Tang Z, Toruner G, Medeiros LJ, Tang G. Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia?. Cancer Med 8(9):4093-4099, 2019. e-Pub 2019. PMID: 31173486.
158. Alfayez M, Wang SA, Bannon SA, Kontoyiannis DP, Kornblau SM, Orange JS, Mace EM, DiNardo CD. Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype. Leuk Lymphoma 60(8):2025-2033, 2019. e-Pub 2019. PMID: 30648453.
159. Quesada AE, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Khoury JD, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, Bannon SA, Benton CB, Garcia-Manero G, Kantarjian H, Luthra R, Medeiros LJ, Patel KP. DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease. Am J Hematol 94(7):757-766, 2019. e-Pub 2019. PMID: 30963592.
160. Saksena A, Yin CC, Xu J, Li J, Zhou J, Wang SA, Lin P, Tang G, Wang L, Wang M, Miranda RN, Medeiros LJ, Li S. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis. Human Pathology 89:71-80, 2019. e-Pub 2019. PMID: 31054894.
161. Xie W, Wang SA, Yin CC, Xu J, Li S, Bueso-Ramos CE, Medeiros LJ, Tang G. Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes. Exp Mol Pathol 108:131-136, 2019. e-Pub 2019. PMID: 31004601.
162. Xu J, Wang L, Li J, Saksena A, Wang SA, Shen J, Hu Z, Lin P, Tang G, Yin CC, Wang M, Medeiros LJ, Li S. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients. American Journal of Surgical Pathology 43(5):710-716, 2019. e-Pub 2019. PMID: 30768440.
163. Loghavi S and Wang SA. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Surg Pathol Cclin, 2019. e-Pub 2019.
164. Tang G, Sydney Sir Philip JK, Weinberg O, Tam W, Sadigh S, Lake JI, Margolskee EM, Rogers HJ, Miranda RN, Bueso-Ramos C C, Hsi ED, Orazi A, Hasserjian RP, Arber DA, Bagg A, Wang SA. Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study. Modern Pathology 32(4):490-498, 2019. e-Pub 2018. PMID: 30401948.
165. Angelova E, Audette C, Kovtun Y, Daver N, Wang SA, Pierce S, Konoplev SN, Khogeer H, Jorgensen JL, Konopleva M, Zweidler-McKay PA, Medeiros LJ, Kantarjian HM, Jabbour EJ, Khoury JD. CD123 expression patterns and selective targeting with a CD123-specific antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia. Haematologica 104(4):749-755, 2019. e-Pub 2018. PMID: 30361418.
166. Tang G, Hu S, Wang SA, Xie W, Lin P, Xu J, Toruner G, Zhao M, Gu J, Doty M, Li S, Medeiros LJ, Tang Z. t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression. Journal of Molecular Diagnostics 21(2):343-351, 2019. e-Pub 2019. PMID: 30576868.
167. Ok CY, Loghavi S, Sui D, Wei P, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Tang G, Tang Z, Jorgensen JL, Luthra R, Ravandi F, Kantarjian HM, DiNardo CD, Medeiros LJ, Wang SA, Patel KP. Persistent IDH1/2 mutation in remission can predict relapse in patients with acute myeloid leukemia. Haematologica 104(2):305-311, 2019. e-Pub 2018. PMID: 30171025.
168. Dalle, IA, Bannon, SA, Patel, KP, Routbort, MJ, Cortes, JE, Ferrajoli, A, Kontoyiannis, DP, Wang, S, DiNardo, C. Germline genetic predisposition to myeloid neoplasia from GATA2 gene mutations. JCO Precision Oncology 3:1-5, 2019. e-Pub 2019. PMID: 32914014.
169. Xie, W, Wang, S, Hu, S, Xu, J, Medeiros, LJ, Tang, G. Myeloproliferative neoplasm with ABL1/ETV6 rearrangement mimics chronic myeloid leukemia and responds to tyrosine kinase inhibitors. Cancer Genetics 228-229:41-46, 2018. e-Pub 2018. PMID: 30553471.
170. Garces S, Khoury JD, Kanagal-Shamanna R, Salem A, Wang SA, Ok CY, Hu S, Patel KP, Routbort MJ, Luthra R, Tang G, Schlette EJ, Bueso-Ramos CE, Medeiros LJ, Loghavi S. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype and TP53 disruption. Hum Pathol 82:215-231, 2018. e-Pub 2018. PMID: 30086334.
171. Mi X, Griffin G, Lee W, Patel S, Ohgami R, Ok CY, Wang S, Geyer JT, Xiao W, Roshal M, Garcia JS, Silverman LB, Sallan SE, Aster JC, Harris MH, Weinberg OK. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations. American Journal of Hematology 93(11):1358-1367, 2018. e-Pub 2018. PMID: 30117174.
172. Hu Z, Boddu PC, Loghavi S, Miranda RN, Goswami M, Medeiros LJ, Tam W, Orazi A, Verstovsek S, Wang SA. A Multimodality Work-up of Patients with Hypereosinophilia. American Journal of Hematology 93(11):1337-1346, 2018. e-Pub 2018. PMID: 30105844.
173. Curry JL, Tetzlaff MT, Wang SA, Landon G, Alouch N, Patel SP, Nagarajan P, Gupta S, Aung PP, Devine CE, Khoury JD, Loghavi S, Prieto VG, DiNardo CD, Gershenwald JE. Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall. American Journal of Dermatopathology 40(11):831-835, 2018. e-Pub 2018. PMID: 29863571.
174. Li L, Zhang J, Chen J, Xu-Monette ZY, Miao Y, Xiao M, Young KH, Wang S, Medeiros LJ, Wang M, Ford RJ, Pham LV. B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma. Blood 132(17):1805-1817, 2018. e-Pub 2018. PMID: 30209121.
175. Liu H, Wang SA, Schlette EJ, Xu J, Jorgensen JL, Cameron Yin C, Li S, Jeffrey Medeiros L, Tang G. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. Ann Hematol 97(10):1775-1783, 2018. e-Pub 2018. PMID: 29872884.
176. Wang, S. Issue Highlights—September 2018 (94B5). Cytometry Part B - Clinical Cytometry 94(5):560-564, 2018. e-Pub 2018. PMID: 30240159.
177. Kadia TM, Cortes J, Ravandi F, Jabbour E, Konopleva M, Benton CB, Burger J, Sasaki K, Borthakur G, DiNardo CD, Pemmaraju N, Daver N, Ferrajoli A, Wang X, Patel K, Jorgensen JL, Wang S, O'Brien S, Pierce S, Tuttle C, Estrov Z, Verstovsek S, Garcia-Manero G, Kantarjian H. Cladribine and low-dose cytarabine alternating with decitabine as front-line therapy for elderly patients with acute myeloid leukaemia: a phase 2 single-arm trial. The Lancet Haematology 5(9):e411-e421, 2018. e-Pub 2018. PMID: 30115541.
178. Wang W, Routbort MJ, Loghavi S, Tang Z, Medeiros LJ, Wang SA. Characterization of chronic myelomonocytic leukemia with TP53 mutations. Leukemia Research 70:97-99, 2018. e-Pub 2018. PMID: 29908419.
179. Shah MV, Jorgensen JL, Saliba RM, Wang SA, Alousi AM, Andersson BS, Bashir Q, Ciurea SO, Kebriaei P, Marin D, Patel KP, Popat UR, Rezvani K, Rondon G, Shpall EJ, Champlin RE, Oran B. Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation 24(7):1514-1520, 2018. e-Pub 2018. PMID: 29448058.
180. Morita K, Kantarjian HM, Wang F, Yan Y, Bueso-Ramos C, Sasaki K, Issa GC, Wang S, Jorgensen J, Song X, Zhang J, Tippen S, Thornton R, Coyle M, Little L, Gumbs C, Pemmaraju N, Daver N, DiNardo CD, Konopleva M, Andreeff M, Ravandi F, Cortes JE, Kadia T, Jabbour E, Garcia-Manero G, Patel KP, Futreal PA, Takahashi K. Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia. Journal of Clinical Oncology 36(18):1788-1797, 2018. e-Pub 2018. PMID: 29702001.
181. Margolskee E, Mikita G, Rea B, Bagg A, Zuo Z, Sun Y, Goswami M, Wang SA, Oak J, Arber DA, Allen MB, George TI, Rogers HJ, Hsi E, Hasserjian RP, Orazi A. A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria. Modern Pathology 31(6):873-880, 2018. e-Pub 2018. PMID: 29403082.
182. Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, Wang SA, Bueso-Ramos CE, Orazi A, Arber DA, Hexner EO, Babushok DV, Bagg A. Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group. Modern Pathology 31(5):690-704, 2018. e-Pub 2018. PMID: 29327708.
183. Kurt H, Jorgensen JL, Amin HM, Patel KP, Wang SA, Lin P, Kanagal-Shamanna R, Loghavi S, Thakral B, Khogeer HA, Jabbour EJ, Li S, Yin CC, Medeiros LJ, Khoury JD. Chronic lymphoproliferative disorder of NK-cells. European Journal of Haematology 100(5):444-454, 2018. e-Pub 2018. PMID: 29385279.
184. Kurt H, Bueso-Ramos CE, Khoury JD, Routbort MJ, Kanagal-Shamanna R, Patel UV, Jorgensen JL, Wang SA, Ravandi F, DiNardo C, Luthra R, Medeiros LJ, Patel KP. Characterization of IDH1 p.R132H Mutant Clones Using Mutation-specific Antibody in Myeloid Neoplasms. American Journal of Surgical Pathology 42(5):569-577, 2018. e-Pub 2018. PMID: 29635257.
185. Sun Y, Tang G, Hu Z, Thakral B, Miranda RN, Medeiros LJ, Wang SA. Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia. Journal of Clinical Pathology 71(4):309-315, 2018. e-Pub 2017. PMID: 28821581.
186. Boddu PC, Wang SA, Pemmaraju N, Tang Z, Hu S, Li S, Xu J, Medeiros LJ, Tang G. 8q24/MYC rearrangement is a recurrent cytogenetic abnormality in blastic plasmacytoid dendritic cell neoplasms. Leukemia Research 66:73-78, 2018. e-Pub 2018. PMID: 29407586.
187. Hidalgo López JE, Carballo-Zarate A, Verstovsek S, Wang SA, Hu S, Li S, Xu J, Zuo W, Tang Z, Yin CC, Medeiros LJ, Bueso-Ramos CE, Tang G. Bone marrow findings in blast phase of polycythemia vera. Annals of Hematology 97(3):425-434, 2018. e-Pub 2018. PMID: 29285580.
188. Quesada AE, Hu Z, Routbort MJ, Patel KP, Luthra R, Loghavi S, Zuo Z, Yin CC, Kanagal-Shamanna R, Wang SA, Jorgensen JL, Medeiros LJ, Ok CY. Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing. Oncotarget 9(9):8441-8449, 2018. e-Pub 2018. PMID: 29492206.
189. Hu Z, Sun Y, Schlette EJ, Tang G, Li S, Xu J, Yin CC, Young KH, Patel KP, Miranda RN, Goswami M, Wang M, Jorgensen JL, Medeiros LJ, Wang SA. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course. Modern Pathology 31(2):327-336, 2018. e-Pub 2018. PMID: 28984300.
190. Li F, Sutherland MK, Yu C, Walter RB, Westendorf L, Valliere-Douglass J, Pan L, Cronkite A, Sussman D, Klussman K, Ulrich M, Anderson ME, Stone IJ, Zeng W, Jonas M, Lewis TS, Goswami M, Wang SA, Senter PD, Law CL, Feldman EJ, Benjamin DR. Characterization of SGN-CD123A, a potent CD123-directed antibody-drug conjugate for acute myeloid leukemia. Molecular cancer therapeutics 17(2):554-564, 2018. e-Pub 2018. PMID: 29142066.
191. Goyal T, Thakral B, Wang SA, Bueso-Ramos CE, Shi M, Jevremovic D, Morice WG, Zhang QY, George TI, Foucar KK, Bhattacharyya S, Bagg A, Rogers HJ, Bodo J, Durkin L, Hsi ED. T-cell large granular lymphocytic leukemia and coexisting B-cell lymphomas. American journal of clinical pathology 149(2):164-171, 2018. e-Pub 2018. PMID: 29365010.
192. Sun Y, Wang SA, Sun T. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma. Cytometry Part B - Clinical Cytometry 94(1):148-150, 2018. e-Pub 2017. PMID: 28109040.
193. Wang W, Routbort MJ, Tang Z, Ok CY, Patel KP, Daver N, Garcia-Manero G, Medeiros LJ, Wang SA. Characterization of TP53 mutations in low-grade myelodysplastic syndromes and myelodysplastic syndromes with a non-complex karyotype. European Journal of Haematology 99(6):536-543, 2017. e-Pub 2017. PMID: 28926144.
194. Jain, N, Lu, X, Daver, N, Thakral, B, Wang, S, Konoplev, SN, Patel, KP, Kanagal Shamanna, R, Valentine, MB, Tang, G, Pemmaraju, N, Jorgensen, JL, Kebriaei, P, Nunez, CA, Wierda, WG, Jabbour, EJ, Roberts, KG, Mullighan, CG, Kantarjian, HM, Konopleva, M. Co-occurrence of CRLF2-rearranged and Ph+ acute lymphoblastic leukemia. Haematologica 102(12):e514-e517, 2017. e-Pub 2017. PMID: 28860345.
195. Arber DA, Borowitz MJ, Cessna M, Etzell J, Foucar K, Hasserjian RP, Rizzo JD, Theil K, Wang SA, Smith AT, Rumble RB, Thomas NE, Vardiman JW. Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. Archives of Pathology and Laboratory Medicine 141(10):1342-1393, 2017. e-Pub 2017. PMID: 28225303.
196. Tang G, Hidalgo Lopez JE, Wang SA, Hu S, Ma J, Pierce S, Zuo W, Carballo-Zarate AA, Yin CC, Tang Z, Li S, Medeiros LJ, Verstovsek S, Bueso-Ramos CE. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera. Haematologica 102(9):1511-1518, 2017. e-Pub 2017. PMID: 28473622.
197. Geyer JT, Tam W, Liu YC, Chen Z, Wang SA, Bueso-Ramos C, Oak J, Arber DA, Hsi E, Rogers HJ, Levinson K, Bagg A, Hassane DC, Hasserjian RP, Orazi A. Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia. Modern Pathology 30(9):1213-1222, 2017. e-Pub 2017. PMID: 28548124.
198. Jain P, Wang S, Patel KP, Sarwari N, Cortes J, Kantarjian H, Verstovsek S. Mast cell leukemia (MCL): Clinico-pathologic and molecular features and survival outcome. Leuk Res 59:105-109, 2017. e-Pub 2017. PMID: 28599188.
199. Wang W, Routbort MJ, Ok CY, Patel KP, Sun Y, Kanagal-Shamanna R, Medeiros LJ, Wang SA. Characterization of TP53 mutations in clonal cytopenia of undetermined significance. American journal of hematology 92(8):E175-E177, 2017. e-Pub 2017. PMID: 28494520.
200. Wang SA, Hasserjian RP, Tam W, Tsai AG, Geyer JT, George TI, Foucar K, Rogers HJ, Hsi ED, Rea BA, Bagg A, Bueso-Ramos C C, Arber DA, Verstovsek S, Orazi A. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified from reactive idiopathic hypereosinophilic syndrome. Haematologica 102(8):1352-1360, 2017. e-Pub 2017. PMID: 28495918.
201. Han L, Jorgensen JL, Brooks C, Shi C, Zhang Q, Nogueras González GM, Cavazos A, Pan R, Mu H, Wang SA, Zhou J, Ai-Atrash G, Ciurea SO, Rettig M, DiPersio JF, Cortes J, Huang X, Kantarjian HM, Andreeff M, Ravandi F, Konopleva M. Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia. Clinical Cancer Research 23(13):3385-3395, 2017. e-Pub 2017. PMID: 28096272.
202. Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M, Wang W, Fang L, Bueso-Ramos CE, Lin P, Medeiros LJ, Lu X. Myeloproliferative Neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: A Meta-Analysis of 20 Cases Shows Cytogenetic Progression with B-Lymphoid Blast Phase. Human Pathology 65:147-156, 2017. e-Pub 2017. PMID: 28551329.
203. Wang SA, Wang YC, Chuang YP, Huang YH, Su WC, Chang WC, Hung JJ. EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis. Oncogene 36(21):2930-2945, 2017. e-Pub 2017. PMID: 27991932.
204. Montalban-Bravo G, Benton CB, Wang SA, Ravandi F, Kadia T, Cortes J, Daver N, Takahashi K, DiNardo C, Jabbour E, Borthakur G, Konopleva M, Pierce S, Bueso-Ramos C, Patel K, Kornblau S, Kantarjian H, Young KH, Garcia-Manero G, Andreeff M. Greater than one TP53 abnormality is a dominant characteristic of pure erythroid leukemia. Blood 129(18):2584-2587, 2017. e-Pub 2017. PMID: 28246192.
205. Hu Z, Medeiros LJ, Fang L, Sun Y, Tang Z, Tang G, Sun T, Quesada AE, Hu S, Wang SA, Pei L, Lu X. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia. American journal of hematology 92(5):441-447, 2017. e-Pub 2017. PMID: 28194886.
206. Rogers HJ, Hsi ED, Tang G, Wang SA, Bueso-Ramos CE, Lubin D, Morrissette JJ, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjian RP. Most myeloid neoplasms with deletion of chromosome 16q are distinct from acute myeloid leukemia with inv(16)(p13.1q22). American journal of clinical pathology 147(4):411-419, 2017. e-Pub 2017. PMID: 28375434.
207. Abaza Y, Yin CC, Bueso-Ramos CE, Wang SA, Verstovsek S. Primary autoimmune myelofibrosis: a case report and review of the literature. International journal of hematology 105(4):536-539, 2017. e-Pub 2016. PMID: 27830539.
208. Gur HD, Wang SA, Tang Z, Hu S, Li S, Medeiros LJ, Tang G. Clinical Significance of Isolated Del(7p) in Myeloid Neoplasms. Leukemia Research 55:18-22, 2017. e-Pub 2017. PMID: 28119224.
209. Zuo W, a WS, DiNardo C, Yabe M, Li S, Medeiros LJ, Tang G. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not MLL gene. Journal of Clinical Pathology 70(3):244-249, 2017. e-Pub 2016. PMID: 27496968.
210. Pemmaraju N, Kantarjian H, Jorgensen JL, Jabbour E, Jain N, Thomas D, O'Brien S, Wang X, Huang X, Wang SA, Konopleva M, Konoplev S, Kadia T, Garris R, Pierce S, Garcia-Manero G, Cortes J, Ravandi F. Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission. American journal of hematology 92(3):279-285, 2017. e-Pub 2017. PMID: 28052371.
211. Jain P, Wang SA, Yin CC, Abaza Y, Verstovsek S, Estrov Z. A case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis. Blood Res 52(1):71-73, 2017. e-Pub 2017. PMID: 28401108.
212. Jain N, Roberts KG, Jabbour E, Patel K, Eterovic AK, Chen K, Zweidler-McKay P, Lu X, Fawcett G, Wang SA, Konoplev S, Harvey RC, Chen IM, Payne-Turner D, Valentine M, Thomas D, Garcia-Manero G, Ravandi F, Cortes J, Kornblau S, O'Brien S, Pierce S, Jorgensen J, Shaw KR, Willman CL, Mullighan CG, Kantarjian H, Konopleva M. Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults. Blood 129(5):572-581, 2017. e-Pub 2017. PMID: 27919910.
213. Wang XJ, Jeffrey Medeiros L, Bueso-Ramos CE, Tang G, Wang S, Oki Y, Desai P, Khoury JD, Miranda RN, Tang Z, Reddy N, Li S. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma. Modern Pathology 30(2):194-203, 2017. e-Pub 2016. PMID: 27739436.
214. Ravandi F, Jorgensen J, Borthakur G, Jabbour E, Kadia T, Pierce S, Brandt M, Wang S, Konoplev S, Wang X, Huang X, Daver N, DiNardo C, Andreeff M, Konopleva M, Estrov Z, Garcia-Manero G, Cortes J, Kantarjian H. Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia. Cancer 123(3):426-435, 2017. e-Pub 2016. PMID: 27657543.
215. 2)Huang L, Wang SA, DiNardo C, Li S, Hu S, Xu J, Zhou W, Goswami M, Medeiros LJ, Tang G. Tetraploidy/near-tetraploidy acute myeloid leukemia. Leukemia Research 53:20-27, 2017. e-Pub 2017. PMID: 27951415.
216. Oran B, Jorgensen JL, Marin D, a WS, Ahmed S, Alousi AM, Andersson BS, Bashir Q, Bassett R, Lyons G, Chen J, Rezvani K, Popat U, Kebriaei P, Patel K, Rondon G, Shpall EJ, Champlin RE. Pretransplantion minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia. Haematologica 102(1):110-117, 2017. e-Pub 2017. PMID: 27540139.
217. Margolskee E, Hasserjian RP, Hassane D, Tam W, Mathew S, Ok CY, Wang SA, Oak J, Arber DA, Orazi A. Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis. American journal of clinical pathology 148(1):49-57, 2017. e-Pub 2017. PMID: 28927162.
218. Tang, G, Bueso-Ramos, CE, Li, S, Medeiros, LJ, Wang, S. Acquired 11q23/MLL rearrangement of unknown clinical significance. International journal of clinical and experimental pathology 10(8):9048-9051, 2017. e-Pub 2017.
219. Yabe M, Medeiros LJ, Wang SA, Tang G, Bueso-Ramos CE, Jorgensen JL, Bhagat G, Chen W, Li S, Young KH, Miranda RN. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. American Journal of Surgical Pathology 41(1):82-93, 2017. e-Pub 2017. PMID: 27755009.
220. Jabbour E, Short NJ, Jorgensen JL, Yilmaz M, Ravandi F, Wang SA, Thomas DA, Khoury J, Champlin RE, Khouri I, Kebriaei P, O'Brien SM, Garcia-Manero G, Cortes JE, Sasaki K, Dinardo CD, Kadia TM, Jain N, Konopleva M, Garris R, Kantarjian H. Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Cancer 123(2):294-302, 2017. e-Pub 2017. PMID: 27602508.
221. Konoplev S, Lu X, Konopleva M, Jain N, Ouyang J, Goswami M, Roberts KG, Valentine M, Mullighan CG, Bueso-Ramos C, Zweidler-McKay PA, Jorgensen JL, Wang SA. CRLF2-positive B-cell acute lymphoblastic leukemia in adult patients. American journal of clinical pathology 147(4):357-363, 2017. e-Pub 2017. PMID: 28340183.
222. Loghavi S, Sa W, Jeffrey Medeiros L, Jorgensen JL, Li X, Xu-Monette ZY, Miranda RN, Young KH. Immunophenotypic and diagnostic characterization of angioimmunoblastic T-cell lymphoma by advanced flow cytometric technology. Leukemia and Lymphoma 57(12):2804-2812, 2016. e-Pub 2016. PMID: 27105079.
223. Huang L, Wang SA, Konoplev S, Bueso-Ramos CE, Thakral B, Miranda RN, Jabbour E, Medeiros LJ, Kanagal-Shamanna R. Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: A case report. Medicine (United States) 95(41):e4934, 2016. e-Pub 2016. PMID: 27741105.
224. Gaballa S, Ge I, El Fakih R, Brammer JE, Kongtim P, Tomuleasa C, Wang SA, Lee D, Petropoulos D, Cao K, Rondon G, Chen J, Hammerstrom A, Lombardi L, Alatrash G, Korbling M, Oran B, Kebriaei P, Ahmed S, Shah N, Rezvani K, Marin D, Bashir Q, Alousi A, Nieto Y, Qazilbash M, Hosing C, Popat U, Shpall EJ, Khouri I, Champlin RE, Ciurea SO. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation. Cancer 122(21):3316-3326, 2016. e-Pub 2016. PMID: 27404668.
225. Huang L, Garcia-Manero G, Jabbour E, Goswami M, Routbort MJ, Medeiros LJ, Jorgensen JL, Wang Sa A. Persistence of immunophenotypically aberrant CD34+ myeloid progenitors is frequent in bone marrow of patients with myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms treated with hypomethylating agents. Journal of Clinical Pathology 69(11):1001-1008, 2016. e-Pub 2016. PMID: 27083210.
226. a WS, Patel KP, Pozdnyakova O, Peng J, Zuo Z, Dal Cin P, Steensma DP, Hasserjian RP. Acute erythroid leukemia with <20% bone marrow blasts is clinically and biologically similar to myelodysplastic syndrome with excess blasts. Modern Pathology 29(10):1221-1231, 2016. e-Pub 2016. PMID: 27443511.
227. Tamamyan GN, Kantarjian HM, Ning J, Jain P, Sasaki K, McClain KL, Allen CE, Pierce SA, Cortes JE, Ravandi F, Konopleva MY, Garcia-Manero G, Benton CB, Chihara D, Rytting ME, Wang Sa A, Abdelall W, Konoplev SN, Daver NG. Malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer 122(18):2857-2866, 2016. e-Pub 2016. PMID: 27244347.
228. Tang Z, Li Y, a WS, Hu S, Li S, Lu X, Khoury JD, Medeiros LJ, Tang G. Clinical significance of acquired loss of the X chromosome in bone marrow. Leukemia Research 47:109-113, 2016. e-Pub 2016. PMID: 27299973.
229. a WS, Tam W, Tsai AG, Arber DA, Hasserjian RP, Geyer JT, George TI, Czuchlewski DR, Foucar K, Rogers HJ, Hsi ED, Bryan Rea B, Bagg A, Dal Cin P, Zhao C, Kelley TW, Verstovsek S, Bueso-Ramos C, Orazi A. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Modern Pathology 29(8):854-64, 2016. e-Pub 2016. PMID: 27174585.
230. Yin CC, Peng J, Li Y, Shamanna RK, Muzzafar T, DiNardo C, Khoury JD, Li S, Medeiros LJ, a WS, Tang G. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Mod Pathol 29(8):939, 2016. e-Pub 2016. PMID: 27469452.
231. Rytting ME, Jabbour EJ, Jorgensen JL, Ravandi F, Franklin AR, Kadia TM, Pemmaraju N, Daver NG, Ferrajoli A, Garcia-Manero G, Konopleva MY, Borthakur G, Garris R, a WS, Pierce S, Schroeder K, Kornblau SM, Thomas DA, Cortes JE, O'Brien SM, Kantarjian HM. Final results of a single institution experience with a pediatric-based regimen, the augmented berlin-frankfurt-münster (ABFM), in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL), and comparison to the hyper-CVAD regimen. American Journal of Hematology 91(8):819-23, 2016. e-Pub 2016. PMID: 27178680.
232. Lopez JE, Yabe M, Carballo-Zarate AA, a WS, Jorgensen JL, Ahmed S, Lee J, Li S, Schlette E, McDonnell T, Miranda RN, Medeiros LJ, Bueso-Ramos CE, Yin CC. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma. JNCCN Journal of the National Comprehensive Cancer Network 14(8):939-944, 2016. e-Pub 2016. PMID: 27496109.
233. Goswami RS, a WS, DiNardo C, Tang Z, Li Y, Zuo W, Hu S, Li S, Medeiros LJ, Tang G. Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasms. Modern Pathology 29(7):727-34, 2016. e-Pub 2016. PMID: 27056073.
234. Xu-Monette ZY, Deng Q, Manyam GC, Tzankov A, Li L, Xia Y, Wang XX, Zou D, Visco C, Dybkær K, Li J, Zhang L, Liang H, Montes-Moreno S, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Parsons BM, Møller MB, a WS, Miranda RN, Piris MA, Winter JN, Medeiros LJ, Li Y, Young KH. Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma. Clinical Cancer Research 22(14):3593-605, 2016. e-Pub 2016. PMID: 26927665.
235. Wang W, Cortes JE, Tang G, Khoury JD, Wang Sa A, Bueso-Ramos CE, DiGiuseppe JA, Chen Z, Kantarjian HM, Medeiros LJ, Hu S. Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood 127(22):2742-50, 2016. e-Pub 2016. PMID: 27006386.
236. Ouyang J, Goswami M, Peng J, Zuo Z, Daver N, Borthakur G, Tang G, Medeiros LJ, Jorgensen JL, Ravandi F, a WS. Comparison of Multiparameter Flow Cytometry Immunophenotypic Analysis and Quantitative RT-PCR for the Detection of Minimal Residual Disease of Core Binding Factor Acute Myeloid Leukemia. American journal of clinical pathology 145(6):769-77, 2016. e-Pub 2016. PMID: 27298396.
237. Wang W, Tang G, Kadia T, Lu X, Li Y, Huang L, Montenegro-Garreaud X, Miranda RN, a WS. Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement. JNCCN Journal of the National Comprehensive Cancer Network 14(6):708-711, 2016. e-Pub 2016. PMID: 27283163.
238. Li Y, Hu S, Sa W, Li S, Huh YO, Tang Z, Medeiros LJ, Tang G. The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia. Modern Pathology 29(5):444-451, 2016. e-Pub 2016. PMID: 26916070.
239. Peng J, Hasserjian RP, Tang G, Patel KP, Goswami M, Jabbour EJ, Garcia-Manero G, Jeffrey Medeiros L, a WS. Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs). Leukemia and Lymphoma 57(4):812-819, 2016. e-Pub 2016. PMID: 26293512.
240. Yabe M, Medeiros LJ, Tang G, Sa W, P Patel K, Routbort M, Bhagat G, Bueso-Ramos CE, Jorgensen JL, Luthra R, Chen W, Muzzafar T, Kanagal-Shamanna R, Khoury JD, Daneshbod Y, Davanlou M, Li S, Young KH, Miranda RN. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. Human Pathology 50:109-117, 2016. e-Pub 2016. PMID: 26997444.
241. Jain P, Tang G, Konoplev SN, Kanagal-Shamanna R, a WS, Pemmaraju N, Daver N, Estrov Z. Synchronous del5q myelodysplastic syndrome (del5qMDS) and adult B cell acute lymphoblastic leukemia (B-ALL) with TET2 and TP53 mutations. American Journal of Hematology 91(3):354-355, 2016. e-Pub 2016. PMID: 26437693.
242. Ravandi F, Jorgensen JL, O'Brien SM, Jabbour E, Thomas DA, Borthakur G, Garris R, Huang X, Garcia-Manero G, Burger JA, Ferrajoli A, Wierda W, Kadia T, Jain N, a WS, Konoplev S, Kebriaei P, Champlin RE, McCue D, Estrov Z, Cortes JE, Kantarjian HM. Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia. British Journal of Hematology 172(3):392-400, 2016. e-Pub 2016. PMID: 26492205.
243. Ok CY, Leventaki V, Wang Sa A, Dinardo C, Medeiros LJ, Konoplev S. Detection of an Abnormal Myeloid Clone by Flow Cytometry in Familial Platelet Disorder With Propensity to Myeloid Malignancy. Am J Clin Pathol 145(2):271-6, 2016. e-Pub 2016. PMID: 26800764.
244. Tang Z, Tang G, Wang Sa A, Lu X, Young KH, Bueso-Ramos CE, Alvarado Y, Medeiros LJ, Khoury JD. Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review. Mol Cytogenet 9(1):23, 2016. e-Pub 2016. PMID: 26925167.
245. Yabe M, Medeiros LJ, Tang G, Wang Sa A, Ahmed S, Nieto Y, Hu S, Bhagat G, Oki Y, Patel KP, Routbort M, Luthra R, Fanale MA, Bueso-Ramos CE, Jorgensen JL, Vega F, Chen W, Hoehn D, Konoplev S, Milton DR, Wistuba I, Li S, You MJ, Young KH, Miranda RN. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. American Journal of Surgical Pathology 40(5):676-88, 2016. e-Pub 2016. PMID: 26872013.
246. Peng J, Zuo Z, Fu B, Oki Y, Tang G, Goswami M, Priyanka P, Muzzafar T, Medeiros LJ, Luthra R, a WS. Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation. European Journal of Haematology 96(1):65-71, 2016. e-Pub 2016. PMID: 25809997.
247. Ok CY, Patel KP, Garcia-Manero G, Routbort MJ, Peng J, Tang G, Goswami M, Young KH, Singh R, Medeiros LJ, Kantarjian HM, Luthra R, Wang S. TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases. Journal of Hematology and Oncology 8(1), 2015. e-Pub 2015. PMID: 25952993.
248. Tang G, Fu B, Hu S, Lu X, Tang Z, Li S, Jabbar K, Khoury JD, Medeiros LJ, Wang S. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia. American Journal of Hematology 90(10):882-887, 2015. e-Pub 2015. PMID: 26148174.
249. Loghavi S, Al-Ibraheemi A, Zuo Z, Garcia-Manero G, Yabe M, Wang S, Kantarjian HM, Yin CC, Miranda RN, Luthra R, Medeiros LJ, Bueso-Ramos CE, Khoury JD. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis. British Journal of Haematology 171(1):91-99, 2015. e-Pub 2015. PMID: 26123119.
250. Yabe M, Medeiros LJ, Wang S, Konoplev S, Ok CY, Loghavi S, Lu G, Flores L, Khoury JD, Cason RC, Young KH, Miranda RN. Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of γδ T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With αβ T-Cell Large Granular Lymphocytic Leukemia. [corrected]. American Journal of Clinical Pathology 144(4):607-619, 2015. e-Pub 2015. PMID: 26386082.
251. Ok CY, Xu-Monette ZY, Li L, Manyam GC, Montes-Moreno S, Tzankov A, Visco C, Dybkær K, Routbort MJ, Zhang L, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Parsons BM, Rao H, Møller MB, Winter JN, Piris MA, Wang S, Medeiros LJ, Young KH. Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions. Modern Pathology 28(9):1202-1213, 2015. e-Pub 2015. PMID: 26111978.
252. Shen Q, Ouyang J, Tang G, Jabbour EJ, Garcia-Manero G, Routbort M, Konoplev S, Bueso-Ramos C, Medeiros LJ, Jorgensen JL, Sa W. Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response. Eur J Haematol 95(2):168-176, 2015. e-Pub 2015. PMID: 25354960.
253. Yin CC, Peng J, Li Y, Shamanna RK, Muzzafar T, DiNardo C, Khoury JD, Li S, Medeiros LJ, Wang S, Tang G. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Modern Pathology 28(8):1014-22, 2015. e-Pub 2015. PMID: 26044451.
254. Ouyang J, Zheng W, Shen Q, Goswami M, Jorgensen JL, Medeiros LJ, Sa W. Flow cytometry immunophenotypic analysis of philadelphia-negative myeloproliferative neoplasms. Cytometry Part B - Clinical Cytometry 88(4):236-243, 2015. e-Pub 2015. PMID: 25557358.
255. Ouyang J, Goswami M, Tang G, Peng J, Ravandi F, Daver N, Routbort M, Konoplev S, Lin P, Medeiros LJ, Jorgensen JL, Wang S. The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemia. American Journal of Hematology 90(6):504-510, 2015. e-Pub 2015. PMID: 25732229.
256. Owusu-Agyemang P, Borthakur G, Rebello E, Arunkumar R, Wang S, Rytting M, Jorgensen JL, Hernandez M, Ruiz JR, Cata JP. The association between opioid administration and response to therapy in patients with acute lymphoblastic leukemia. Leukemia and Lymphoma 56(6):1903-1905, 2015. e-Pub 2015. PMID: 25363399.
257. Cleven AH, Nardi V, Ok CY, Goswami M, Dal Cin P, Zheng Z, Iafrate AJ, Abdul Hamid MA, Wang S, Hasserjian RP. High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome. Modern Pathology 28(4):552-563, 2015. e-Pub 2015. PMID: 25412846.
258. Ok CY, Patel KP, Garcia-Manero G, Routbort MJ, Fu B, Tang G, Goswami M, Singh R, Kanagal-Shamanna R, Pierce SA, Young KH, Kantarjian HM, Medeiros LJ, Luthra R, Wang S. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Leukemia Research 39(3):348-354, 2015. e-Pub 2015. PMID: 25573287.
259. DiNardo CD, Tang G, Pemmaraju N, Wang S, Pike A, Garcia-Manero G, Cortes J, Bueso-Ramos C, Kantarjian HM. Acute myeloid leukemia with t(10;11). Clinical Lymphoma, Myeloma and Leukemia 15(1):47-51, 2015. e-Pub 2015. PMID: 25081372.
260. Tang G, DiNardo C, Zhang L, Ravandi F, Khoury JD, Huh YO, Muzzafar T, Medeiros LJ, Wang S, Bueso-Ramos CE. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Human Pathology 46(1):65-73, 2015. e-Pub 2015. PMID: 25387813.
261. Yin CC, Jain N, Mehrotra M, Zhagn J, Protopopov A, Zuo Z, Pemmaraju N, DiNardo C, Hirsch-Ginsberg C, Wang S, Medeiros LJ, Chin L, Patel KP, Ravandi F, Futreal A, Bueso-Ramos CE. Identification of a Novel Fusion Gene, IRF2BP2-RARA, in Acute Promyelocytic Leukemia. J Natl Compr Canc Netw 13(1):19-22, 2015. e-Pub 2015. PMID: 25583766.
262. Hasserjian RP, Campigotto F, Klepeis V, Fu B, Wang S, Bueso-Ramos C, Cascio MJ, Rogers HJ, Hsi ED, Soderquist C, Bagg A, Yan J, Ochs R, Orazi A, Moore F, Mahmoud A, George TI, Foucar K, Odem J, Booth C, Morice W, DeAngelo DJ, Steensma D, Stone RM, Neuberg D, Arber DA. De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults. American Journal of hematology 89(11):E193-9, 2014. e-Pub 2014. PMID: 25042343.
263. Gay CM, William WN, Wang S, Oo TH. Thymoma complicated by acquired amegakaryocytic thrombocytopenia and pure red cell Aplasia. JNCCN Journal of the National Comprehensive Cancer Network 12(11):1505-9, 2014. e-Pub 2014. PMID: 25361796.
264. Jabbar KJ, Medeiros LJ, Wang S, Miranda RN, Johnson MR, Verstovsek S, Jorgensen JL. Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow. Archives of Pathology and Laboratory Medicine 138(9):1210-1214, 2014. e-Pub 2014. PMID: 25171703.
265. Tang G, Zhang L, Fu B, Hu J, Lu X, Hu S, Patel A, Goswami M, Khoury JD, Garcia-Manero G, Medeiros LJ, Wang S. Cytogenetic Risk Stratification of 417 Patients with Chronic Myelomonocytic Leukemia from a Single Institution. American journal of hematology 89(8):813-818, 2014. e-Pub 2014. PMID: 24782398.
266. Zhou Y, Slack R, Jorgensen JL, Wang S, Rondon G, de Lima M, Shpall E, Popat U, Ciurea S, Alousi A, Qazilbash M, Hosing C, O'Brien S, Thomas D, Kantarjian H, Medeiros LJ, Champlin RE, Kebriaei P. The effect of peritransplant minimal residual disease in adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation. Clin Lymphoma Myeloma Leuk 14(4):319-326, 2014. e-Pub 2014. PMID: 24548609.
267. Tang G, Wang S, Lu V, Lee HC, Qazilbash MH, Wang XI, Yin CC, Orlowski R, Wang Y, Patel A, Medeiros LJ, Lu G. Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms. Leukemia Research 38(8):896-900, 2014. e-Pub 2014. PMID: 24939217.
268. Ok CY, Wang S, Amin HM. Leukemic Phase of ALK(+) Anaplastic Large-Cell Lymphoma, Small-Cell Variant. Clinical Lymphoma, Myeloma and Leukemia 14(4):e123-e126, 2014. e-Pub 2014. PMID: 24685107.
269. Rogers HJ, Vardiman JW, Anastasi J, Raca G, Savage NM, Cherry AM, Arber D, Moore E, Morrissette JJ, Bagg A, Liu YC, Mathew S, Orazi A, Lin P, Wang S, Bueso-Ramos CE, Foucar K, Hasserjian RP, Tiu RV, Karafa M, Hsi ED. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). Haematologica 99(5):821-829, 2014. e-Pub 2014. PMID: 24463215.
270. Fu B, Jaso JM, Sargent RL, Goswami M, Verstovsek S, Medeiros LJ, Wang S. Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems. Modern Pathology 27(5):681-689, 2014. e-Pub 2014. PMID: 24186132.
271. Wang S, Hasserjian RP, Fox PS, Rogers HJ, Geyer JT, Chabot-Richards D, Weinzierl E, Hatem J, Jaso J, Kanagal-Shamanna R, Stingo FC, Patel KP, Mehrotra M, Bueso-Ramos C, Young KH, Dinardo CD, Verstovsek S, Tiu RV, Bagg A, Hsi ED, Arber DA, Foucar K, Luthra R, Orazi A. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. Blood 123(17):2645-2651, 2014. e-Pub 2014. PMID: 24627528.
272. Alexanian, R, Wang, L, Delasalle, K, Wang, S, Qazilbash, MH, Handy, BC, Weber, DM. Value of novel agents and intensive therapy for patients with multiple myeloma. Bone marrow transplantation 49(3):422-425, 2014. e-Pub 2014. PMID: 24317125.
273. Zheng W, Medeiros LJ, Young KH, Goswami M, Powers L, Kantarjian HH, Thomas DA, Cortes JE, Wang S. CD30 expression in acute lymphoblastic leukemia as assessed by flow cytometry analysis. Leuk Lymphoma 55(3):624-7, 2014. e-Pub 2014. PMID: 23937105.
274. Ok CY, Hasserjian RP, Fox PS, Stingo F, Zuo Z, Young KH, Patel K, Medeiros LJ, Garcia-Manero G, Wang S. Application of the international prognostic scoring System-Revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia. Leukemia 28(1):185-189, 2014. e-Pub 2014. PMID: 23787392.
275. Tang G, Lu X, a WS, Roney EK, Zhang L, Hu S, Lu G, Medeiros LJ, Patel A. Homozygous inv(11)(q21q23) and MLL gene rearrangement in two patients with myeloid neoplasms. International journal of clinical and experimental pathology 7(6):3196-201, 2014. e-Pub 2014. PMID: 25031740.
276. Wang S, Tzankov A, Xu-Monette ZY, Hoeller S, Wang SA, Richards KL, Zhang S, Said JW, Medeiros LJ, Young KH. Clonally related composite follicular lymphoma and mantle cell lymphoma with clinicopathologic features and biological implications. Human Pathology 44(12):2658-2667, 2013. e-Pub 2013. PMID: 24071012.
277. Jaso JM, Yin CC, Wang S, Miranda RN, Jabcuga CE, Chen L, Medeiros LJ. Clinicopathologic Features of CD5-Positive Nodal Marginal Zone Lymphoma. American journal of clinical pathology 140(5):693-700, 2013. e-Pub 2013. PMID: 24124149.
278. Jain P, Le X, Young KH, Patel KP, Wang S, Pei L, Barron LL, Abruzzo L, O'Brien S. Sequential lymphomas or clonally unrelated Richter syndrome of chronic lymphocytic leukemia into mantle cell lymphoma. Clinical Lymphoma, Myeloma and Leukemia 13(5):606-9, 2013. e-Pub 2013. PMID: 23763914.
279. Fu B, Ok CY, Goswami M, Xei W, Jaso JM, Muzzafar T, Bueso-Ramos C, Verstovsek S, Garcia-Manero G, Medeiros LJ, Wang S. The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes. Annals of Hematology 92(10):1335-1343, 2013. e-Pub 2013. PMID: 23660629.
280. Wei Y, Dimicoli S, Bueso-Ramos C, Chen R, Yang H, Neuberg D, Pierce S, Jia Y, Zheng H, Wang H, Wang X, Nguyen M, Wang S, Ebert B, Bejar R, Levine R, Abdel-Wahab O, Kleppe M, Ganan-Gomez I, Kantarjian H, Garcia-Manero G. Toll-like receptor alterations in myelodysplastic syndrome. Leukemia 27(9):1832-1840, 2013. e-Pub 2013. PMID: 23765228.
281. Ravandi F, Jorgensen JL, Thomas DA, O'Brien S, Garris R, Faderl S, Huang X, Wen S, Burger JA, Ferrajoli A, Kebriaei P, Champlin RE, Estrov Z, Challagundla P, Wang S, Luthra R, Cortes JE, Kantarjian HM. Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy. Blood 122(7):1214-1221, 2013. e-Pub 2013. PMID: 23836561.
282. Zheng W, Liu D, Fan X, Powers L, Goswami M, Hu Y, Lin P, Medeiros LJ, Wang S. Potential Therapeutic Biomarkers in Plasma Cell Myeloma: A Flow Cytometry Study. Cytometry Part B - Clinical Cytometry 84(4):222-228, 2013. e-Pub 2013. PMID: 23450831.
283. Zheng W, Medeiros LJ, Hu Y, Powers L, Cortes JE, Ravandi-Kashani F, Kantarjian HH, Wang S. CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes. Clinical Lymphoma, Myeloma and Leukemia 13(3):307-14, 2013. e-Pub 2013. PMID: 23313069.
284. Wang S, Hutchinson L, Tang G, Chen SS, Miron PM, Huh YO, Jones DM, Bueso-Ramos C, Verstovsek S, Medeiros LJ, Miranda RN. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease. American journal of hematology 88(3):219-224, 2013. e-Pub 2013. PMID: 23440662.
285. Daver N, Strati P, Jabbour E, Kadia T, Luthra R, Wang S, Patel K, Ravandi F, Cortes J, Qin Dong X, Kantarjian H, Garcia-Manero G. FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia. American journal of hematology 88(1):56-59, 2013. e-Pub 2013. PMID: 23115106.
286. Xu-Monette ZY, Møller MB, Tzankov A, Montes-Moreno S, Hu W, Manyam GC, Kristensen L, Fan L, Visco C, Dybkaer K, Chiu A, Tam W, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJ, Wu L, Zhao X, Bueso-Ramos CE, Wang S, Go RS, Li Y, Winter JN, Piris MA, Medeiros LJ, Young KH. MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy. Blood 122(15):2630-2640, 2013. e-Pub 2013. PMID: 23982177.
287. Ciurea SO, Mulanovich V, Saliba RM, Bayraktar UD, Jiang Y, Bassett R, Wang S, Konopleva M, Fernandez-Vina M, Montes N, Bosque D, Chen J, Rondon G, Alatrash G, Alousi A, Bashir Q, Korbling M, Qazilbash M, Parmar S, Shpall E, Nieto Y, Hosing C, Kebriaei P, Khouri I, Popat U, de Lima M, Champlin RE. Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 18(12):1835-1844, 2012. e-Pub 2012. PMID: 22796535.
288. Zhou Y, Jorgensen JL, Wang S, Ravandi F, Cortes J, Kantarjian HM, Medeiros LJ, Konoplev S. Usefulness of CD11a and CD18 in flow cytometric immunophenotypic analysis for diagnosis of acute promyelocytic leukemia. American journal of clinical pathology 138(5):744-50, 2012. e-Pub 2012. PMID: 23086776.
289. Kanagal-Shamanna R, Medeiros LJ, Lu G, Wang S, Manning JT, Lin P, Penn GM, Young KH, You MJ, Vega F, Bassett R, Miranda RN. High-grade B cell lymphoma, unclassifiable, with blastoid features. Histopathology doi: 10.1111/j.1365-2559.2012.04301.x(5):945-54, 2012. e-Pub 2012. PMID: 22804688.
290. Liu D, Lin P, Hu Y, Zhou Y, Tang G, Powers L, Medeiros LJ, Jorgensen JL Wang S. Immunophenotypic heterogeneity of normal plasma cells. Journal of Clinical Pathology 65(9):823-829, 2012. e-Pub 2012. PMID: 22685235.
291. Tang G, Jorgensen LJ, Zhou Y, Hu Y, Kersh M, Garcia-Manero G, Medeiros LJ, Wang S. Multi-color CD34 + progenitor-focused flow cytometric assay in evaluation of myelodysplastic syndromes in patients with post cancer therapy cytopenia. Leukemia Research 36(8):974-981, 2012. e-Pub 2012. PMID: 22626984.
292. Zuo Z, Medeiros LJ, Chen Z, Liu D, Bueso-Ramos CE, Luthra R, Wang S. Acute myeloid leukemia (AML) with erythroid predominance exhibits clinical and molecular characteristics that differ from other types of AML. PloS one 7(7):e41485, 2012. e-Pub 2012. PMID: 22844482.
293. Nardi V, Winkfield KM, Ok CY, Niemierko A, Kluk MJ, Attar EC, Garcia-Manero G, Wang S, Hasserjian RP. Acute myeloid leukemia and myelodysplastic syndromes after radiation therapy are similar to de novo disease and differ from other therapy-related myeloid neoplasms. Journal of Clinical Oncology 30(19):2340-2347, 2012. e-Pub 2012. PMID: 22585703.
294. Kanagal-Shamanna R, Bueso-Ramos CE, Barkoh B, Lu G, Wang S, Garcia-Manero G, Vadhan-Raj S, Hoehn D, Medeiros LJ, Yin CC. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Cancer 118(11):2879-2888, 2012. e-Pub 2012. PMID: 22038701.
295. Tang G, Zuo Z, Thomas DA, Lin P, Liu D, Hu Y, Kantarjian HM, Bueso-Ramos C, Medeiros LJ, Wang S. Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies. Haematologica 97(6):919-925, 2012. e-Pub 2012. PMID: 22207681.
296. Liu W, Medeiros LJ, Lin P, Romaguera JE, Wang S, Jorgensen JL. Usefulness of flow cytometric immunophenotyping for bone marrow staging in patients with mantle cell lymphoma after therapy. American journal of clinical pathology 137(4):634-640, 2012. e-Pub 2012. PMID: 22431541.
297. Kantarjian H, Thomas D, Jorgensen J, Jabbour E, Kebriaei P, Rytting M, York S, Ravandi F, Kwari M, Faderl S, Rios MB, Cortes J, Fayad L, Tarnai R, Wang S, Champlin R, Advani A, O'Brien S. Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia. The lancet oncology 13(4):403-411, 2012. e-Pub 2012. PMID: 22357140.
298. Zhou Y, Tang G, Medeiros LJ, McDonnell TJ, Keating MJ, Wierda WG, Wang S. Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Modern Pathology 25(2):237-45, 2012. e-Pub 2012. PMID: 22080061.
299. Wang SA, Hasserjian RP. Erythroid proliferations in myeloid neoplasms. Human Pathology 43(2):153-164, 2012. e-Pub 2012. PMID: 22154053.
300. Ok CY, Medeiros LJ, Hu Y, Bueso-Ramos CE, Wang S. Transient/reversible ring sideroblasts in bone marrow of patients post cytotoxic therapies for primary malignancies. Leukemia Research 35(12):1605-1610, 2011. e-Pub 2011. PMID: 21596435.
301. Ciurea SO, Thall PF, Wang X, Wang S, Hu Y, Cano P, Aung F, Rondon G, Molldrem JJ, Korbling M, Shpall EJ, de Lima M, Champlin RE, Fernandez-Vina M. Donor-specific anti-HLAAbs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood 118(22):5957-5964, 2011. e-Pub 2011. PMID: 21967975.
302. Jaso J, Thomas DA, Cunningham K, Jorgensen JL, Kantarjian HM, Medeiros LJ, Wang S. Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B-lymphoblastic leukemia in the era of tyrosine kinase inhibitors. Cancer 117(17):4009-4017, 2011. e-Pub 2011. PMID: 21365622.
303. Hao S, Smith TW, Chu PG, Liu Q, Ok CY, Woda BA, Lu D, Lin P, Wang S, Dresser K, Rock KL, Jiang Z. The oncofetal protein IMP3. Archives of Pathology and Laboratory Medicine 135(8):1032-1036, 2011. e-Pub 2011. PMID: 21809995.
304. Tang G, Wang S, Menon M, Dresser K, Woda BA, Hao S. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes. Leukemia Research 35(6):766-70, 2011. e-Pub 2011. PMID: 21367453.
305. Vigil CE, Wang S, Cortes JE, Bueso-Ramos C, Verstovsek S, Shinder R, Chen SS, Katz RL, Khanna A, Esmaeli B, Manning JT, You MJ, Miranda RN. Dasatinib responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase. Journal of Clinical Oncology 29(17):e514-e516, 2011. e-Pub 2011. PMID: 21464405.
306. Ma X, Wang R, Galili N, Mayne ST, a WS, Yu H, Raza A. Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes. Cancer Causes and Control 22(4):623-9, 2011. e-Pub 2011. PMID: 21287258.
307. Liu W, Hasserjian RP, Hu Y, Zhang L, Miranda RN, Medeiros LJ, Wang S. Pure erythroid leukemia. Modern Pathology 24(3):375-383, 2011. e-Pub 2011. PMID: 21102413.
308. Wang S, Abruzzo LV, Hasserjian RP, Zhang L, Hu Y, Zhang Y, Zhao M, Galili N, Raza A, Medeiros LJ, Garcia-Manero G, Miranda RN. Myelodysplastic syndromes with deletions of chromosome 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features. Leukemia Research 35(3):351-7, 2011. e-Pub 2011. PMID: 20691474.
309. Hasserjian RP, Zuo Z, Garcia C, Tang GL, Kasyan A Luthra R, Abruzzo LV, Kantarjian HM, Medeiros LJ, a WS. Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification. Blood 115(10):1985-92, 2011. e-Pub 2011.
310. Alseraye FM, Zuo Z, Bueso-Ramos C, Wang S, Medeiros LJ, Lu G. Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation. Int J Clin Exp Pathol 4(4):371-377, 2011. e-Pub 2011. PMID: 21577323.
311. Hasserjian RP, Zuo Z, Garcia C, Tang G, Kasyan A, Luthra R, Abruzzo LV, Kantarjian HM, Medeiros LJ, Wang S. Acute erythroid leukemia. Blood 115(10):1985-1992, 2010. e-Pub 2010. PMID: 20040759.
312. Feng B, Jorgensen JL, Jones D, Chen SS, Hu Y, Medeiros LJ, Wang S. Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor VΒ chain antibodies and its application in blood staging. Modern Pathology 23(2):284-295, 2010. e-Pub 2010. PMID: 19935642.
313. Feng B, Jorgensen JL, Hu Y, Medeiros LJ, Wang S. TCR-Vbeta flow cytometric analysis of peripheral blood for assessing clonality and disease burden in patients with T cell large granular lymphocyte leukaemia. Journal of Clinical Pathology 63(2):141-146, 2010. e-Pub 2010. PMID: 20154036.
314. Wang S, Jabbar K, Lu G, Chen SS, Galili N, Vega F, Jones D, Raza A, Kantarjian H, Garcia-Manero G, McDonnell TJ, Medeiros LJ. Trisomy 11 in myelodysplastic syndromes defines a unique group of disease with aggressive clinicopathologic features. Leukemia 24(4):740-7, 2010. e-Pub 2010. PMID: 20072149.
315. Tang G, Woods LJ, Wang S, Brettler D, Andersen M, Miron PM, Pechet L, Woda BA, Hao S. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Human Pathology 40(8):1194-1199, 2009. e-Pub 2009. PMID: 19427022.
316. Truong F, Smith BR, Stachurski D, Cerny J, Medeiros LJ, Woda BA, Wang S. The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow. Leukemia Research 33(8):1039-1046, 2009. e-Pub 2009. PMID: 19232722.
317. Gustafson SA, Lin P, Chen SS, Chen L, Abruzzo LV, Luthra R, Medeiros LJ, Wang S. Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21) (q22;q22) but does not have a favorable outcome. American journal of clinical pathology 131(5):647-655, 2009. e-Pub 2009. PMID: 19369623.
318. Cerny J, Wang S, Miron P, Hutchinson L, Brettler D. EBV-negative Hodgkin lymphoma in ZAP-70-positive B-cell lymphocytic leukemia patient. Annals of Hematology 88(5):495-497, 2009. e-Pub 2009. PMID: 18843488.
319. Pozdnyakova O, Crowley-Larsen P, Zota V, Wang S, Miron PM. Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment. Cancer Genetics and Cytogenetics 189(2):112-117, 2009. e-Pub 2009. PMID: 19215792.
320. Fadare O, Carns B, Vos JA, Wang S. Clinicopathologic features associated with cytohistologic noncorrelation in the diagnosis of cervical dysplasia: a study of concurrently obtained samples. International Journal of Surgical Pathology 17(1):31-37, 2009. e-Pub 2009. PMID: 18480391.
321. Muzzafar T, Medeiros LJ, Wang S, Brahmandam A, Thomas DA, Jorgensen JL. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia. American journal of clinical pathology 132(5):692-698, 2009. e-Pub 2009. PMID: 19846809.
322. Wang S, Pozdnyakova O, Jorgensen JL, Medeiros LJ, Stachurski D, Anderson M, Raza A, Woda BA. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica 94(1):29-37, 2009. e-Pub 2009. PMID: 19001281.
323. Pozdnyakova O, Miron PM, Tang G, Walter O, Raza A, Woda B, Wang S. Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer 113(12):3331-3340, 2008. e-Pub 2008. PMID: 18988232.
324. Wang S, Tang G, Fadare O, Hao S, Raza A, Woda BA, Hasserjian RP. Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification. Modern Pathology 21(11):1394-1402, 2008. e-Pub 2008. PMID: 18839018.
325. Fadare O, Orejudos MP, Jain R, Mariappan MR, Hecht JL, Renshaw IL, Hileeto D, Wang S, Ghofrani M, Liang SX. A comparative analysis of lymphatic vessel density in ovarian serous tumors of low malignant potential (borderline tumors) with and without lymph node involvement. International Journal of Gynecological Pathology 27(4):483-490, 2008. e-Pub 2008. PMID: 18753975.
326. Cerny J, Fadare O, Hutchinson L, Wang S. Clinicopathological features of extramedullary recurrence/relapse of multiple myeloma. European Journal of Haematology 81(1):65-69, 2008. e-Pub 2008. PMID: 18462256.
327. Yue G, Hao S, Fadare O, Baker S, Pozdnyakova O, Galili N, Woda BA, Raza A, Wang S. Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome. Leukemia Research 32(4):553-558, 2008. e-Pub 2008. PMID: 17888511.
328. Desrosiers L, Fadare O, Xiao ZF, Dresser K, Wang S. Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium. Annals of Diagnostic Pathology 12(2):112-117, 2008. e-Pub 2008. PMID: 18325471.
329. Fadare O, Wang S, Hileeto D. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast. Human Pathology 39(3):331-336, 2008. e-Pub 2008. PMID: 18261623.
330. Hochberg JC, Miron PM, Hay BN, Woda BA, Wang S, Richert-Przygonska M, Aprikyan AA, Newburger PE. Mosaic tetraploidy and transient GFI1 mutation in a patient with severe chronic neutropenia. Pediatric Blood and Cancer 50(3):630-632, 2008. e-Pub 2008. PMID: 17096407.
331. Stachurski D, Smith BR, Pozdnyakova O, Andersen M, Xiao Z, Raza A, Woda BA, Wang S. Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases. Leukemia Research 32(2):215-24, 2008. e-Pub 2008. PMID: 17675229.
332. Zota V, Miron PM, Woda BA, Raza A, Wang S. Eosinophilia with FIP1L1-PDGFRA fusion in a patient with chronic myelomonocytic leukemia. Journal of Clinical Oncology 26(12):2040-2041, 2008. e-Pub 2008. PMID: 18421057.
333. Tang G, Truong F, Fadare O, Woda B, Wang S. Diagnostic challenges related to myeloid/natural killer cells, a variant of myeloblasts. Int J Clin Exp Pathol 1(6):544-9, 2008. e-Pub 2008. PMID: 18787634.
334. Fadare O, Wang S, Renshaw IL. Does the radiofrequency impedance-controlled endometrial ablation have any morphologic effects on uterine leiomyomata? Report of 3 cases. Diagnostic pathology 3(1):28, 2008. e-Pub 2008. PMID: 18593468.
335. Wang S, Yue G, Hutchinson L, Landry ML, Hasserjian RP, Hao S, Galili N, Raza A, Woda BA. Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion [1]. Br J Haematol 138(2):271-275, 2007. e-Pub 2007. PMID: 17542981.
336. Stachurski D, Miron PM, Al-Homsi S, Hutchinson L, Harris NL, Woda B, Wang S. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24. Human Pathology 38(6):940-945, 2007. e-Pub 2007. PMID: 17509395.
337. Fadare O, Desrosiers L, Xiao ZF, Wang S. How often does cervical involvement upstage patients with non-myoinvasive (otherwise stage 1A) endometrioid adenocarcinoma of the endometrium?. Virchows Archiv 450(5):601-2, 2007. e-Pub 2007. PMID: 17406893.
338. Wang S, Galili N, Cerny J, Sechman E, Chen SS, Loew J, Liu Q, Fadare O, Hasserjian R, Jones D, Qawi H, Woda B, Raza A. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. American journal of clinical pathology 126(5):789-797, 2006. e-Pub 2006. PMID: 17050076.
339. Fadare O, Dadmanesh F, Alvarado-Cabrero I, Snyder R, Stephen Mitchell J, Tot T, Wang S, Ghofrani M, Eusebi V, Martel M, Tavassoli FA. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases. American Journal of Surgical Pathology 30(11):1445-1453, 2006. e-Pub 2006. PMID: 17063087.
340. Wang S, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S, Liu Q, Zhao W, Mehdi M, Galili N, Woda B, Raza A. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia 20(9):1641-1644, 2006. e-Pub 2006. PMID: 16871284.
341. Wang S, Fadare O, Nagar A, Shafi NQ, Rose MG. Gastrointestinal endoscopic findings in men with unexplained anemia and low normal ferritin values. American journal of hematology 81(5):324-327, 2006. e-Pub 2006. PMID: 16628728.
342. Wang S, Olson N, Zukerberg L, Harris NL. Splenic marginal zone lymphoma with micronodular T-cell rich B-cell lymphoma. American Journal of Surgical Pathology 30(1):128-132, 2006. e-Pub 2006. PMID: 16330953.
343. Wang S, Rahemtullah A, Faquin WC, Roepke J, Harris NL, Hasserjian RP. Hodgkin's lymphoma of the thyroid: a clinicopathologic study of five cases and review of the literature. Modern Pathology 18(12):1577-1584, 2005. e-Pub 2005. PMID: 16258502.
344. Wang, S, Wang, L, Hochberg, EP, Muzikansky, A, Harris, NL, Hasserjian, RP. Low histologic grade follicular lymphoma with high proliferation index. American Journal of Surgical Pathology 29(11):1490-1496, 2005. e-Pub 2005. PMID: 16224216.
345. Wang S, Wang L, Hochberg EP, Muzikansky A, Harris NL, Hasserjian RP. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features. Am J Surg Pathol 29(11):1490-6, 2005. e-Pub 2005.
346. Rassidakis, GZ, Thomaides, A, Wang, S, Jiang, Y, Fourtouna, A, Lai, R, Medeiros, LJ. p53 gene mutations are uncommon but p53 is commonly expressed in anaplastic large-cell lymphoma. Leukemia 19(9):1663-1669, 2005. e-Pub 2005. PMID: 15990866.
347. Dalton, RR, Rassidakis, GZ, Atwell, C, Wang, S, Oyarzo, M, Medeiros, LJ. Differential expression of cyclin D3 in ALK+ and ALK- anaplastic large cell lymphoma. Human Pathology 36(7):806-811, 2005. e-Pub 2005. PMID: 16084951.
348. Fadare, O, Mariappan, MR, Hileeto, D, Wang, S, McAlpine, JN, Rimm, DL. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Modern Pathology 18(5):673-680, 2005. e-Pub 2005. PMID: 15578078.
349. Fadare O, Mariappan MR, Hileeto D Wang S, McAlpine JN, Rimm DL. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol 18(5):673-80, 2005. e-Pub 2005.
350. Drut R, Wang S, Parkash V. Corkscrew-like malformations of umbilical cord. Pediatr Dev Pathol 8(1):137-8, 2005. e-Pub 2005.
351. Wang, S, Degar, BA, Zieske, A, Shafi, NQ, Rose, MG. Hemophagocytosis exacerbated by G-CSF/GM-CSF treatment in a patient with myelodysplasia. American journal of hematology 77(4):391-396, 2004. e-Pub 2004. PMID: 15551287.
352. Wang S, Degar BA, Zieske A, Shafi NQ, Rose MG. Hemophagocytosis exacerbated by myeloid growth factors in a patient with myelodysplasia. Am J Hematol 77(4):391-6, 2004. e-Pub 2004.
353. Wang S, Li N, Heald P, Fisk JM, Fadare O, Howe JG, McNiff JM, Smith BR. Flow cytometric DNA ploidy analysis of peripheral blood from patients with sezary syndrome: detection of aneuploid neoplastic T cells in the blood is associated with large cell transformation in tissue. Am J Clin Pathol 122(5):774-82, 2004. e-Pub 2004.
354. Fadare, O, Mariappan, MR, Wang, S, Hileeto, D, McAlpine, JN, Rimm, DL. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings. Cancer 102(3):150-156, 2004. e-Pub 2004. PMID: 15211473.
355. Yeh, MM, Tang, LH, Wang, S, Robert, M, Zheng, W, Jain, D. Inhibin expression in ovarian-type stroma in mucinous cystic neoplasms of the pancreas. Applied Immunohistochemistry and Molecular Morphology 12(2):148-152, 2004. e-Pub 2004. PMID: 15354741.
356. Fadare O, Maraippan MR, Wang S, Hileeto D, McAlpine J, Rimm DL. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings. Cancer 102(3):150-6, 2004. e-Pub 2004.
357. Yeh MM, Tang LH, Wang S, Robert ME, Zheng W, Jain D. Inhibin expression in ovarian-type stroma in mucious cystic neoplasm of the pancreas. Appl Immunohistochem Mol Morphol 12(2):148-52, 2004. e-Pub 2004.
358. Fadare O, Wang S, Mariappan MR. Practice patterns of clinicians following isolated diagnoses of atypical small acinar proliferation on prostate biopsy specimens. Archives of Pathology and Laboratory Medicine 128(5):557-560, 2004. e-Pub 2004. PMID: 15086303.
359. Fadare O, Wang S, Mariappan MR. Pathologic quiz case: a 69-year-old asymptomatic man with a scrotal mass. Atypical (symplastic or bizarre) leiomyoma of the scrotum. Arch Pathol Lab Med 128(2):e37-8, 2004. e-Pub 2004. PMID: 14736263.
360. Wang, S, Fadare, O. An 11-Year-Old Boy with Acute-Onset Right Lower Abdominal Pain. Archives of Pathology and Laboratory Medicine 128(2):239-240, 2004. e-Pub 2004. PMID: 14736272.
361. Jung, HW, La, SJ, Kim, JY, Heo, SK, Kim, JY, Wang, S, Kim, KK, Lee, KM, Cho, HR, Lee, HW, Kwon, B, Kim, BS, Kwon, BS. High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases. Experimental and Molecular Medicine 35(6):501-508, 2003. e-Pub 2003. PMID: 14749527.
362. Wang, S, Ernst, LM, Smith, BR, Tallini, G, Howe, JG, Crouch, J, Cooper, D. Systemic Tropheryma whippleii Infection Associated with Monoclonal B-Cell Proliferation. Archives of Pathology and Laboratory Medicine 127(12):1619-1622, 2003. e-Pub 2003. PMID: 14632565.
363. Jung HW, La SJ, Kim JY, Heo SK, Kim JY, Wang S, Kim KK, Lee KM, Cho HR, Lee HW, Kwon B, Kim BS, Kwon BS. High levels of soluble herpes virus entry mediator in sera of patients with allergic and autoimmune diseases. Exp Mol Med 35(6):501-508, 2003. e-Pub 2003.
364. Wang T, Scully E, Yin Z, Kim JH, Wang S, Yan J, Mamula M, Anderson JF, Craft J, Fikrig E. IFN-gamma-producing gamma-delta T cells help control murine West Nile virus infection. J Immunol 171(5):2524-31, 2003. e-Pub 2003.
365. Wang, S, Pudney, J, Song, J, Mor, G, Schwartz, P, Zheng, W. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia - Precursor of endometrial cancer. Gynecologic oncology 88(2):108-117, 2003. e-Pub 2003. PMID: 12586588.
366. Wang S, Pudney J, Song J, Mor G, Schwartz PE, Zheng W. Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer. Gynecol Oncol 88(2):108-17, 2003. e-Pub 2003.
367. Li XL, Shen SR, Wang S, Ouyang HH, Li GC. Restoration of T cell-specific V(D)J recombination in DNA-PKcs(-/-) mice by ionizing radiation: The effects on survival, development, and tumorigenesis. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34(2):149-157, 2002. e-Pub 2002. PMID: 12006988.
368. Wang, S, Guo, M, Ouyang, H, Li, X, Cordon-Cardo, C, Kurimasa, A, Chen, D, Fuks, Z, Ling, CC, Li, GC. The catalytic subunit of DNA-dependent protein kinase selectively regulates p53-dependent apoptosis but not cell-cycle arrest. Proceedings of the National Academy of Sciences of the United States of America 97(4):1584-1588, 2000. e-Pub 2000. PMID: 10677503.
369. Wang S, Guo M, Ouyang HH, Li XL, Cardo CC, Kurimasa A, Chen DJ, Fuks Z, Ling CC and Li GC. DNA-PKcs deficiency selectively suppresses radiation-induced P53-dependent apoptosis but not cell cycle checkpoints function. Proc Natl Acad Sci USA 97(4):1584-8, 2000. e-Pub 2000.
370. Hu JY, Wang S, Zhu JG, Sun QB. Anti-colorectal cancer active immunity induced by B-7 gene modified tumor cells. Chinese J Clin Oncol 27(2):137-41, 2000. e-Pub 2000.
371. Kurimasa, A, Ouyang, H, Dong, LJ, Wang, S, Li, X, Cordon-Cardo, C, Chen, D, Li, GC. Catalytic subunit of DNA-dependent protein kinase. Proceedings of the National Academy of Sciences of the United States of America 96(4):1403-1408, 1999. e-Pub 1999. PMID: 9990036.
372. Kurimasa A, Ouyang HH, Dong IJ, Wang S, Li XL, Cordon-Cardo C, Chen DJ, Li GC. Catalytic subunit of DNA-dependent protein kinase: Impact on lymphocyte development and tumorigenisis. Proc Natl Acad Sci USA 96(4):1403-08, 1999. e-Pub 1999.
373. Hu JY, Wang S, Zhu JG, Sun QB. Expression of B7 costimulation molecules by colorectal cancer cells reduces tumorigenicity and induces anti-tumor immunity. World J Gastroenterol 5(2):147-51, 1999. e-Pub 1999.
374. Zhai Y, Guo R, Hsu TL, Yu GL, Ni J, Kwon BS, Jiang GW, Lu J, Tan J, Ugustus M, Carter K, Rojas L, Zhu F, Lincoln C, Endress G, Xing L, Wang S, Oh KO, Gentz R, Ruben S, Lippman ME, Hsieh SL, Yang D. LIGHT, a novel ligand for lymphotoxin beta receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 102(6):1142-1151, 1998. e-Pub 1998. PMID: 9739048.
375. Wang, S, Kim, YJ, Bick, C, Kim, SH, Kwon, BS. The potential roles of 4-1BB costimulation in HIV type 1 infection. AIDS Research and Human Retroviruses 14(3):223-231, 1998. e-Pub 1998. PMID: 9491912.
376. Wang S, Kim YJ, Bick BC, Kim SH, Kwon BS. The potential role of 4-1BB costimulation in HIV-1 infected lymphocytes. AIDS Res hum Retroviruses 14(3):223-31, 1998. e-Pub 1998.
377. Kwon BS, Wang S, Udagawa N, Haridas V, Lee ZH, Kim KK, Oh KO, Greene J, Li Y, Su J, Gentz R, Aggarwal BB, Ni J. TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB Journal 12(10):845-854, 1998. e-Pub 1998. PMID: 9657524.
378. Kwon, BS, Tan, KB, Ni, J, Kwi-Ok-Oh, Lee, ZH, Kim, KK, Kim, YJ, Wang, S, Gentz, R, Yu, GL, Harrop, J, Lyn, SD, Silverman, C, Porter, TG, Truneh, A, Young, PR. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. Journal of Biological Chemistry 272(22):14272-14276, 1997. e-Pub 1997. PMID: 9162061.
379. Kwon BS, Tan KB, Oh J, Lee ZH, Kim KK, Kim YJ, Wang S, Gentz R, Yu GL, Harrop J. A new identified member of the tumor necrosis factor receptor surperfamily with a wide tissue distribution and involement in lymphocyte activation. J Biol Chem 272(22):14272-76, 1997. e-Pub 1997.
380. Wang S, Zhu JO, Li XL, Sun QB. Study the regulation of interferon on the expression and shedding of colonic cancer associated antigens by mAbs(cc-1 etc.). Chin J Immunol 11:52-5, 1995. e-Pub 1995.
381. Yang JF, Wang S, Sun QB. Preparation and characterization of anti-idiotype mAbs bearing the internal image of nasopharyngeal cancer associated antigen. Labeled Immunoassays and Clinical Medicine 1(3):79-83, 1994. e-Pub 1994.
382. Wang S, Sun QB. Production and characterization of CC- 1 second generation mAbs by intrasplenic deposited immunization with minute amounts of antigen. Chin Med J 107(7):548-51, 1994. e-Pub 1994.
383. Wang S, Young JF, Sun QB. Comparison of the CC-1 with its second generation mAbs W-135 and A12-2 in TAA binding specificity using immunohistochemical and immunoblotting analyses. Chin J Immunol 10(4):2-19-22S, 1994. e-Pub 1994.
384. Goulart H, Ravandi F, Short NJ, Jain N, Daver N, Kadia TM, DiNardo C, Borthakur G, Takahashi K, Pemmaraju N, Haddad FG, Bravo GM, Alvarado Y, Issa GC, Bataller A, Pierce S, Loghavi S, Tang G, Wang SA, Thakral B, Shpall E, Champlin R, Khouri I, Kebriaei P, Garcia-Manero G, Sasaki K, Jabbour EJ, Senapati J. Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia. PMID: 41370732.

Review Articles

1. Wang SA, Arenillas L, Buccisano F, Bruggemann M, Kern W, Menes M, Plesa A, Stone L, Wellnitz D, Westerman DA, Wood BL, Freeman SD. Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panel, 2026. PMID: 40905082.
2. Foucar K, Bagg A, Arber DA, Bueso-Ramos CE, Geyer JT, Hasserjian RP, Orazi A, Reichard KK, Tam W, Wang SA, Weinberg OK, Hsi ED. Guide to the diagnosis of lymphoid neoplasms in blood and bone marrow: A Bone Marrow Pathology Group approach, 2025. e-Pub 2025. PMID: 40994023.
3. Fang H, Wang SA, Medeiros LJ, Wang W. Application of flow cytometry immunophenotypic analysis for the diagnosis of mature B-cell lymphomas/leukemias. Hum Pathol 156:105711, 2024. e-Pub 2024. PMID: 39709144.
4. Komrokji RS, Lanino L, Ball S, Bewersdorf JP, Marchetti M, Maggioni G, Travaglino E, Al Ali NH, Fenaux P, Platzbecker U, Santini V, Diez-Campelo M, Singh A, Jain AG, Aguirre LE, Tinsley-Vance SM, Schwabkey ZI, Chan O, Xie Z, Brunner AM, Kuykendall AT, Bennett JM, Buckstein R, Bejar R, Carraway HE, DeZern AE, Griffiths EA, Halene S, Hasserjian RP, Lancet J, List AF, Loghavi S, Odenike O, Padron E, Patnaik MM, Roboz GJ, Stahl M, Sekeres MA, Steensma DP, Savona MR, Taylor J, Xu ML, Sweet K, Sallman DA, Nimer SD, Hourigan CS, Wei AH, Sauta E, D'Amico S, Asti G, Castellani G, Delleani M, Campagna A, Borate UM, Sanz G, Efficace F, Gore SD, Kim TK, Daver N, Garcia-Manero G, Rozman M, Orfao A, Wang SA, Foucar MK, Germing U, Haferlach T, Scheinberg P, Miyazaki Y, Iastrebner M, Kulasekararaj A, Cluzeau T, Kordasti S, van de Loosdrecht AA, Ades L, Zeidan AM, Della Porta MG. Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes. Lancet Haematol 11(11):e862-e872, 2024. e-Pub 2024. PMID: 39393368.
5. Foucar, K, Bagg, A, Bueso-Ramos, CE, George, T, Hasserjian, RP, Hsi, ED, Orazi, A, Tam, W, Wang, S, Weinberg, OK, Arber, DA. Guide to the Diagnosis of Myeloid Neoplasms. American journal of clinical pathology 160(4):365-393, 2023. e-Pub 2023. PMID: 37391178.
6. Wang, S, Orazi, A, Gotlib, J, Reiter, A, Tzankov, A, Hasserjian, RP, Arber, DA, Tefferi, A. The international consensus classification of eosinophilic disorders and systemic mastocytosis. American journal of hematology 98(8):1286-1306, 2023. e-Pub 2023. PMID: 37283522.
7. Ohgami RS, Aung PP, Gru AA, Hussaini M, Singh K, Querfeld C, Yao K, Small C, Gollapudi S, Jaye D, Wang SA, Pullarkat S, George TI. An Analysis of the Pathologic Features of Blastic Plasmacytoid Dendritic Cell Neoplasm Based on a Comprehensive Literature Database of Cases. Archives of Pathology and Laboratory Medicine 147(7):837-846, 2023. e-Pub 2023. PMID: 36170615.
8. Leguit RJ, Wang SA, George TI, Tzankov A, Orazi A. The international consensus classification of mastocytosis and related entities. Virchows Arch 482(1):99-112, 2023. e-Pub 2022. PMID: 36214901.
9. Hasserjian RP, Orazi A, Orfao A, Rozman M, Wang SA. The International Consensus Classification of myelodysplastic syndromes and related entities. Virchows Arch 482(1):39-51, 2023. e-Pub 2022. PMID: 36287260.
10. Tzankov A, Reichard KK, Hasserjian RP, Arber DA, Orazi A, Wang SA. Updates on eosinophilic disorders. Virchows Arch 482(1):85-97, 2023. e-Pub 2022. PMID: 36068374.
11. Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, Wang SA, Bagg A, Barbui T, Branford S, Bueso-Ramos CE, Cortes JE, Dal Cin P, DiNardo CD, Dombret H, Duncavage EJ, Ebert BL, Estey EH, Facchetti F, Foucar K, Gangat N, Gianelli U, Godley LA, Gökbuget N, Gotlib J, Hellström-Lindberg E, Hobbs GS, Hoffman R, Jabbour EJ, Kiladjian JJ, Larson RA, Le Beau MM, Loh ML, Löwenberg B, Macintyre E, Malcovati L, Mullighan CG, Niemeyer C, Odenike OM, Ogawa S, Orfao A, Papaemmanuil E, Passamonti F, Porkka K, Pui CH, Radich JP, Reiter A, Rozman M, Rudelius M, Savona MR, Schiffer CA, Schmitt-Graeff A, Shimamura A, Sierra J, Stock WA, Stone RM, Tallman MS, Thiele J, Tien HF, Tzankov A, Vannucchi AM, Vyas P, Wei AH, Weinberg OK, Wierzbowska A, Cazzola M, Döhner H, Tefferi A. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140(11):1200-1228, 2022. e-Pub 2022. PMID: 35767897.
12. El Hussein S, Wang SA, Pemmaraju N, Khoury JD, Loghavi S. Chronic myelomonocytic leukemia. Journal of Immunotherapy and Precision Oncology 4(3):142-149, 2021. e-Pub 2021. PMID: 35663104.
13. El Hussein S, Wang W, Wang SA, Loghavi S, Wang X, Qiu L, Fang H, Medeiros LJ, Aung PP, Torres Cabala C, Jorgensen JL, Pemmaraju N, Khoury JD. Blastic plasmacytoid dendritic cell neoplasm with history of myeloma and concomitant acute undifferentiated leukemia: Illustration of morphologic and immunophenotypic challenges of an emerging phenomenon. Leuk Lymphoma 62(13):3296-3299, 2021. e-Pub 2021. PMID: 34304666.
14. Horna P, Wang SA, Wolniak KL, Psarra K, Almeida J, Illingworth AJ, Johansson U, Craig FE, Torres R. Flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides. Cytometry Part B - Clinical Cytometry 100(2):142-155, 2021. e-Pub 2021. PMID: 32319723.
15. Illingworth A, Johansson U, Huang S, Horna P, Wang SA, Almeida J, Wolniak KL, Psarra K, Torres R, Craig FE. International guidelines for the flow cytometric evaluation of peripheral blood for suspected Sézary syndrome or mycosis fungoides. Cytometry B Clin Cytom 100(2):156-182, 2021. e-Pub 2021. PMID: 33112044.
16. Pozdnyakova O, Orazi A, Kelemen K, King R, Reichard KK, Craig FE, Quintanilla-Martinez L, Rimsza L, George TI, Horny HP, Wang SA. Myeloid/Lymphoid Neoplasms Associated with Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or with PCM1-JAK2. American journal of clinical pathology 155(2):160-178, 2021. e-Pub 2021. PMID: 33367495.
17. Tzankov A, Duncavage E, Craig FE, Kelemen K, King RL, Orazi A, Quintanilla-Martinez L, Reichard KK, Rimsza LM, Wang SA, Horny HP, George TI. Mastocytosis. American journal of clinical pathology 155(2):239-266, 2021. e-Pub 2021. PMID: 33313644.
18. King RL, Tan B, Craig FE, George TI, Horny HP, Kelemen K, Orazi A, Reichard KK, Rimsza LM, Wang SA, Zamo A, Quintanilla-Martinez L. Reactive Eosinophil Proliferations in Tissue and the Lymphocytic Variant of Hypereosinophilic Syndrome. American journal of clinical pathology 155(2):211-238, 2021. e-Pub 2021. PMID: 33367482.
19. Mattis DM, Wang SA, Lu CM. Contemporary classification and diagnostic evaluation of hypereosinophilia. Am J Clin Pathol 154(3):305-318, 2020. e-Pub 2020. PMID: 32525541.
20. Cossarizza A, Chang HD, Radbruch A, Acs A, Adam D, Adam-Klages S, Agace WW, Aghaeepour N, Akdis M, Allez M, Almeida LN, Alvisi G, Anderson G, Andrä I, Annunziato F, Anselmo A, Bacher P, Baldari CT, Bari S, Barnaba V, Barros-Martins J, Battistini L, Bauer W, Baumgart S, Baumgarth N, Baumjohann D, Baying B, Bebawy M, Becher B, Beisker W, Benes V, Beyaert R, Blanco A, Boardman DA, Bogdan C, Borger JG, Borsellino G, Boulais PE, Bradford JA, Brenner D, Brinkman RR, Brooks AES, Busch DH, Büscher M, Bushnell TP, Calzetti F, Cameron G, Cammarata I, Cao X, Cardell SL, Casola S, Cassatella MA, Cavani A, Celada A, Chatenoud L, Chattopadhyay PK, Chow S, Christakou E, Cicin-Šain L, Clerici M, Colombo FS, Cook L, Cooke A, Cooper AM, Corbett AJ, Cosma A, Cosmi L, Coulie PG, Cumano A, Cvetkovic L, Dang VD, Dang-Heine C, Davey MS, Davies D, De Biasi S, Del Zotto G, Dela Cruz GV, Delacher M, Della Bella S, Dellabona P, Deniz G, Dessing M, Di Santo JP, Diefenbach A, Dieli F, Dolf A, Dörner T, Dress RJ, Dudziak D, Dustin M, Dutertre CA, Ebner F, Eckle SBG, Edinger M, Eede P, Ehrhardt GRA, Eich M, Engel P, Engelhardt B, Erdei A, Esser C, Everts B, Evrard M, Falk CS, Fehniger TA, Felipo-Benavent M, Ferry H, Feuerer M, Filby A, Filkor K, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frehse B, Frenette PS, Frischbutter S, Fritzsche W, Galbraith DW, Gangaev A, Garbi N, Gaudilliere B, Gazzinelli RT, Geginat J, Gerner W, Gherardin NA, Ghoreschi K, Gibellini L, Ginhoux F, Goda K, Godfrey DI, Goettlinger C, González-Navajas JM, Goodyear CS, Gori A, Grogan JL, Grummitt D, Grützkau A, Haftmann C, Hahn J, Hammad H, Hämmerling G, Hansmann L, Hansson G, Harpur CM, Hartmann S, Hauser A, Hauser AE, Haviland DL, Hedley D, Hernández DC, Herrera G, Herrmann M, Hess C, Höfer T, Hoffmann P, Hogquist K, Holland T, Höllt T, Holmdahl R, Hombrink P, Houston JP, Hoyer BF, Huang B, Huang FP, Huber JE, Huehn J, Hundemer M, Hunter CA, Hwang WYK, Iannone A, Ingelfinger F, Ivison SM, Jäck HM, Jani PK, Jáveg. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur J Immunol 49(10):1457-1973, 2019. e-Pub 2019. PMID: 31633216.
21. Loghavi, S, Wang, S. Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Surgical Pathology Clinics 12(3):651-669, 2019. e-Pub 2019. PMID: 31352979.
22. Wang SA. The Diagnostic Work-Up of Hypereosinophilia.Proceedings of XIII EBMWG International Course and Workshop on Bone Marrow Pathology. Pathobiology 86(1):1-14, 2019. e-Pub 2019. PMID: 29961056.
23. Tang G, Medeiros LJ, Wang SA. How I investigate Clonal cytogenetic abnormalities of undetermined significance. International Journal of Laboratory Hematology 40(4):385-391, 2018. e-Pub 2018. PMID: 29624895.
24. Xu J, Jorgensen JL, Wang SA. How Do We Use Multicolor Flow Cytometry to Detect Minimal Residual Disease in Acute Myeloid Leukemia?. Clinics in Laboratory Medicine 37(4):787-802, 2017. e-Pub 2017. PMID: 29128069.
25. Daver N, McClain K, Allen CE, Parikh SA, Otrock Z, Rojas-Hernandez C, Blechacz B, Wang S, Minkov M, Jordan MB, La Rosée P, Kantarjian HM. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer 123(17):3229-3240, 2017. e-Pub 2017. PMID: 28621800.
26. Wang W, Wang SA, Medeiros LJ, Khoury JD. Pure Erythroid Leukemia. American journal of hematology 92(3):292-296, 2017. e-Pub 2017. PMID: 28006859.
27. Wang SA, Hasserjian RP. Acute erythroleukemias, acute megakaryoblastic leukemias, and reactive mimics. American Journal of Clinical Pathology 144(1):44-60, 2015. e-Pub 2015. PMID: 26071461.
28. Jaso JM, Wang SA, Jorgensen JL, Lin P. Multi-color flow cytometric immunophenotyping for detection of minimal residual disease in AML: past, present and future. Bone Marrow Transplant 49(9):1129-38, 2014. e-Pub 2014. PMID: 24842529.
29. Zhang L, Wang Sa. A focused review of hematopoietic neoplasms occurring in the therapy-related setting. International Journal of clinical and experimental pathology 7(7):3512-3523, 2014. e-Pub 2014. PMID: 25120730.
30. Wang SA. Diagnosis of Myelodysplastic Syndromes in Cytopenic Patients. Hematology/Oncology Clinics of North America 25(5):1085-1110, 2011. e-Pub 2011. PMID: 22054736.
31. Greaves, W, Wang, S. Selected Topics on Lymphoid Lesions in the Head and Neck Regions. Head and Neck Pathology 5(1):41-50, 2011. e-Pub 2011. PMID: 21287407.
32. Wang, S. Diagnosis of Myelodysplastic Syndromes in Cytopenic Patients. Surgical Pathology Clinics 3(4):1127-1152, 2010. e-Pub 2010. PMID: 26839301.
33. Wang, SA. Diagnosis of Myelodysplastic Syndromes in Cytopenic Patients. Current Concepts in Hematopathology 3(4):1127-52, 2010. e-Pub 2010.
34. Wang, S, Li, N, Heald, PW, Fisk, JM, Fadare, O, Howe, JG, McNiff, JM, Smith, BR. Flow cytometric DNA ploidy analysis of peripheral blood from patients with Sézary syndrome. American journal of clinical pathology 122(5):774-782, 2004. e-Pub 2004. PMID: 15491974.
35. Wang, SA, Sun QB. Modulation by recombination human interferon of TAA expression and shedding. Overseas Medicine 14(2):80-81, 1994. e-Pub 1994.
36. Wang Sa, Sun QB. The B7 and its role in T cell based cancer research. Overseas Medicine: Oncology Section 21:62-63, 1994. e-Pub 1994.

Professional Educational Materials

1. A Wang MCAS. Acute leukemia diagnostic guideline Pocket book. American Society of Hematology (https://hematology-staging.herokuapp.com/#/app/home, 2017.

Other Articles

1. Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y, Kuipers J, Loghavi S, Wang SA, Yan Y, Furudate K, Matthews J, Little L, Gumbs C, Zhang J, Song X, Thompson E, Patel KP, Bueso-Ramos CE, DiNardo CD, Ravandi F, Jabbour E, Andreeff M, Cortes J, Bhalla K, Garcia-Manero G, Kantarjian H, Konopleva M, Nakada D, Navin N, Beerenwinkel N, Futreal PA, Takahashi K Publisher Correction: Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nature communications 11(1), 2020. PMID: 33214561.
2. Thakral B, Wang SA T-cell prolymphocytic leukemia negative for surface CD3 and CD45. Blood 132(1):111, 2018. PMID: 29976781.
3. Thakral B, Wang SA "Hof" in pronormoblasts: pure erythroid leukemia mimicking plasma cell myeloma. Blood 130(13):1600, 2017. PMID: 28963106.
4. Yabe, M, Medeiros, LJ, Wang, S Erratum. American journal of clinical pathology 144(5):823, 2015. PMID: 26486749.
5. Hasserjian RP, Wang Sa Hematopathology: SC14-1 CHALLENGES IN BONE MARROW PATHOLOGY. Pathology 46 Suppl 2:S21, 2014. PMID: 25188096.
6. Quesada A, Reynolds M, Jorgensen JL, Wang Sa Cytokine receptor-like factor 2 (CRLF2) Expression in Precursor B-lymphoblastic Leukemia. The International Clinical Cytometry Society e-Newsletter 5(1), 2014.
7. Fan XS, Wang SA Advances in blastic plasmacytoid dendritic cell neoplasm. Chinese Journal of Pathology 42(2):131-134, 2013. PMID: 23710925.
8. Feske M, Wang SA, Nguyen T, Jorgenson JL Standardization and Reagent Cocktail Optimization for Multicolor Flow Cytometry In Texas Laboratories. The International Clinical Cytometry Society 4(3), 2013.
9. Illingworth A, Craig F, Ward R, Wang Sa Specimen Preparation Survey Summary. The International Clinical Cytometry Society 4(2), 2013.
10. Fan XS, Wang SA Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. Chinese Journal of Pathology 41(11):779-783, 2012. PMID: 23302345.
11. Drut, R, Wang, S, Parkash, V Re. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 8(1):137-138, 2005. PMID: 15717116.
12. Wang Sa, McPhedran P Use of D-Dimer Assays in the diagnosis of venous thrombosis (Review). Lab News 43(1):4-6, 1994.

Editorials

1. Rimsza L, Craig FE, Reichard KK, Kelemen K, George TI, Horny HP, Orazi A, Quintanilla-Martinez L, Wang SA, King RL. Addressing the Challenges of Eosinophilia and Mastocytosis. American journal of clinical pathology 155(2):156-159, 2021. PMID: 33367532.
2. Wang SA, Czader MB. Focused reviews of practical flow cytometry applications in hematopathology. Cytometry Part B - Clinical Cytometry 96(1):19, 2019. PMID: 30549177.
3. Wang, Sa. Editorial Highlights Cytometry B. Clinical Cytometry, 2018.
4. Wang, Sa. The International Clinical Cytometry Society. Newsletter, 2016.

Abstracts

1. Wang SA, Abruzzo LV, Hasserjian RP, Medeiros LJ, Miranda RN. Myelodysplastic syndromes with interstitial deletions of 11q lack cryptic 11q23 translocations and exhibit characteristic clinicopathologic features. 99th Annual Meeting of the USCAP, Mod Pathol 23:327A, 2010. e-Pub 2010.
2. Wang SA, Jabbar K, Lu G, McDonnell TJ, Medeiros LJ. Trisomy 11 in Myelodysplastic Syndromes Defines a Unique Group with Aggressive Clinicopathologic Features. 99th Annual Meeting of the USCAP 23:327A, 2010. e-Pub 2010.
3. Liu W, Hasserjian RP, Liping Z, Medeiros LJ, Wang SA. AML M6b (FAB): a re-evaluation using the 2008 WHO criteria. 99th Annual Meeting of the USCAP, Mod Pathol 23:308A-9A, 2010. e-Pub 2010.
4. Miranda RN, Tang G, Jones DM, Huy YO, Medeiros LJ, Wang SA. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disorder (SM-AHNMD) shows distinct hematologic features and reveals a common clonal origin of myeloid and mast cells. 99th Annual Meeting of the USCAP. Mod Pathol 23:311A-12A, 2010. e-Pub 2010.
5. Feng B, Jorgensen JL, Hu Y, Medeiros LJ, Wang SA. TCR-V beta flow cytometric analysis of peripheral blood for assessing clonality and disease burden in patients with T cell large granular lymphocyte leukaemia. J Clin Pathol 63(141-46), 2010. e-Pub 2010.
6. Jaso J, Cunningham K, Medeiros LJ, Jorgensen JL, Thomas D, Wang SA. Flow cytometry immunophenotypic, molecular and cytogenetic characteristics of Philadelphia (Ph)-positive B lymphoblastic leukemia. Mod Pathol 23:303A, 2010. e-Pub 2010.
7. Feng B, Jorgensen JL, Jones D, Chen SS, Hu Y, Medeiros LJ, Wang S. Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sezary syndrome using T-cell receptor V beta chain antibodies and its application in blood staging. Mod Pathol 23(2):284-95, 2010. e-Pub 2010.
8. Menon MP, Hao SY, Woda BA, Wang SA. Flow cytometry immunophenotyping in plasma cell dyscrasia: pros and cons. Cytometry Part B-Clinical Cytometry 76B:402-3, 2009. e-Pub 2009.
9. Muzzafar T, Medeiros LJ, Wang SA, Brahmandam A, Thomas DA, Jorgensen JL. Aberrant underexpression of CD81 in precursor B-cell acute lymphoblastic leukemia: utility in detection of minimal residual disease by flow cytometry. Am J Clin Pathol 132(5):692-98, 2009. e-Pub 2009.
10. Truong F, Smith BR, Stachurski D, Cerny J, Medeiros LJ, Woda BA, Wang SA. The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: A prospective study. Leuk Res 33(8):1039-46, 2009. e-Pub 2009.
11. Tang GL, Woods LJ, Wang SA, Brettle D, Andersen M, Miron PM, Pechet L, Woda BA, Hao SY. Chronic basophilic leukemia: a rare form of chronic myeloproliferative neoplasm. Hum Pathol 40(8):1194-99, 2009. e-Pub 2009.
12. Gustafson SA, Lin P, Chen SS, Chen L, Abruzzo LV, Luthra R, Medeiros LJ, Wang SA. Therapy-related acute myeloid leukemia with t(8;21) (q22;q22) shares many features with de novo acute myeloid leukemia with t(8;21)(q22;q22) but does not have a favorable outcome. Am J Clin Pathol 131(5):647-55, 2009. e-Pub 2009.
13. Pozdnyakova O, Crowley-Larsen P, Zota V, Wang SA, Miron PA. Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment. Cancer Genet Cytogenet 189(2):112-17, 2009. e-Pub 2009.
14. Feng B, Jorgensen JL, Medeiros LJ, Wang SA. Assessing clonality and disease burden of T-cell large granular lymphocyte leukemia (T-LGL) by TCR-V beta flow cytometric analysis. Lab Invest 89:262A-63A, 2009. e-Pub 2009.
15. Hao S, Smith TW, Chu PG, Liu Q, Woda BA, Lu D, Lin P, Wang S, Rock KL, Jiang Z. The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma. Mod Pathol 22:330A, 2009. e-Pub 2009.
16. Wang S, Pozdnyakova O, Jorgensen JL, Medeiros LJ, Stachurski D, Anderson M, Raza A, Woda BA. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica 94(1):29-37, 2009. e-Pub 2009.
17. Pozdnyakova O, Miron PM, Tang GL, Walter O, Raza A, Woda B, Wang SA. Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities. Cancer 113(12):3331-40, 2008. e-Pub 2008.
18. Wang SA, Tang GL, Fadare O, Hao SY, Raza A, Woda BA, Hasserjian RP. Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification. Mod Pathol 21(11):1394-02, 2008. e-Pub 2008.
19. Fadare O, Desrosiers L, Xiao ZF, Wang SA. How often does cervical involvement upstage patients with non-myoinvasive (otherwise stage 1A) endometrioid adenocarcinoma of the endometrium?. Virchows Arch 450(5):601-2, 2007. e-Pub 2007.
20. Wang SA, Galili N, Cerny J, Sechman E, Chen SS, Loew J, Liu Q, Fadare O, Hasserjian R, Jones D, Qawi H, Woda B, Raza A. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de Novo disease. Am J Clin Pathol 126(5):789-97, 2006. e-Pub 2006.
21. Fadare O, Dadmanesh F, Alvarado-Cabrero, Snyder R, Mitchell S, Tot T, Wang SA, Ghofrani M, Eusebi V, Martel M, tavassolli FA. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis - A clinicopothologic study of 78 cases. Am J Surg Pathol 30(11):1445-53, 2006. e-Pub 2006.
22. Desrosiers L, Wang SA, Fadare O. Lymphovascular space invasion in stage I endometrioid adenocarcinoma of the endometrium: Incidence and prognostic significance. Am J Clin Pathol 126(4):658, 2006. e-Pub 2006.
23. Wang SA, Hasserjian RP, Loew JM, Sechman EV, Jones D, Hao S, Liu Q, Zhao W, Mehdi M, Galili N, Woda B, Raza A. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis harbors JAK2 mutation and shows overlapping myeloproliferative and myelodysplastic features. Leukemia 20(9):1641-44, 2006. e-Pub 2006.

Book Chapters

1. Hsi ED, Maciejewski JP, Shi M, and Wang SA. T-Cell Large Granular Lymphocytic Leukemia. In: The International Consensus Classification of Myeloid and Lymphoid Neoplasms, 2025.
2. Wang SA, Gotinib J, Reichard K, Reiter A, Tzankov A. Myeloid/Lymphoid Neoplasm with Eosinophilia and Tyrosine Kinase Gene Fusion. In: The International Consensus Classification of Myeloid and Lymphoid Neoplasms, 2025.
3. Thakral B, Wang SA. Myeloproliferative and "Overlap" Myelodysplastic/Myeloproliferative Neoplasms. In: Hematopathology (Fourth Edition), 2025.
4. Reichard K, George TI, Gotlib J, Leguit R, Orazi A, Reiter A, Tefferi A, Tzankov A, and Wang SA. Mastocytosis. In: : The International Consensus Classification of Myeloid and Lymphoid Neoplasms, 2025.
5. Dearden C, Bachy E, López C, and Wang SA. T-Cell Prolymphocytic Leukemia. In: The International Consensus Classification of Myeloid and Lymphoid Neoplasms, 2025.
6. Pozdnyakova O, Bennett JM, DeZern AE, and Wang SA. Myelodysplastic Syndrome. In: The International Consensus Classification of Myeloid and Lymphoid Neoplasms, 2025.
7. Pizzi M, Onida F, Orazi A, Prakash S, Wang SA. Atypical Chronic Myeloid Leukemia. In: Hematopathology (Fourth Edition), 2025.
8. Hsi ED, Maciejewski JP, Shi M, and Wang SA. Chronic Lymphoproliferative Disorder of Natural Killer Cells. In: The International Consensus Classification of Myeloid and Lymphoid Neoplasms, 2025.
9. Wang SA, Orazi A, Reichard K, Tefferi A. Chronic Eosinophilic Leukemia, NOS. In: The International Consensus Classification of Myeloid and Lymphoid Neoplasms, 2025.
10. Reichard K, Wang SA, Arber DA, and Orazi A. Eosinophilia, Chronic Eosinophilic Leukemia, Not Otherwise Specified, and Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions. In: In Hematopathology 2nd edition, 2022. Jaffe E, Aber DA, Campo E, Quintanilla-Fend L and Orazi A, 999-1021.e4, 2024.
11. Wang, Miranda. Myeloid neoplasms with Eosinohipia. In: Diagnostic Bone Marrow Hematopathology (Jon van der Walt, Dan Arber and Attillio Orazi). Cambridge University Press, 2021.
12. Punia, JN, Wang, S, Elghetany, MT. Inherited bone marrow failure syndromes, myeloid neoplasms with germline predisposition and myeloid proliferations associated with down syndrome. In: In: Diagnosis of Blood and Bone Marrow Disorders. Wang SA and Hasserjian RP, 81-117, 2018.
13. Thakral, B, Wang, S. Thrombocytosis. In: In: Diagnosis of Blood and Bone Marrow Disorders. Wang SA and Hasserjian RP, 225-242, 2018.
14. Wang, S. Cytopenias. In: In: Diagnosis of Blood and Bone Marrow Disorders, 119-134, 2018.
15. Wang, S. T- and NK-cell lymphocytosis. In: Diagnosis of Blood and Bone Marrow Disorders. Wang SA and Hasserjian RP, 281-328, 2018.
16. Loghavi, S, Wang, S. Mixed cytoses and cytopenias. In: Diagnosis of Blood and Bone Marrow Disorders. Wang SA and Hasserjian RP, 257-279, 2018.
17. Miranda, R, Wang, S. Leukocytosis Eosinophilia. In: Diagnosis of Blood and Bone Marrow Disorders. Wang SA and Hasserjian RP, 171-193, 2018.
18. Thakral, B, Anastasi, J, Wang, S. Myeloproliferative and "Overlap" Myelodysplastic/Myeloproliferative Neoplasms. In: Hematopathology (Third Edition). Hdi ED, 488-538.e4, 2018.
19. Wang S. Dermatopathic lymphoadenopathy. In: Diagnostic Pathology: Nonneoplastic Pediatrics (Putman). Amirsys Inc, 2013.
20. Wang S. Hemophagocytic Lymphohistiocytosis. In: Diagnostic Pathology: Nonneoplastic Pediatrics (Putman). Amirsys Inc, 2013.
21. Wang S. Diffuse Large B cell lymphoma, leg type. In: Diagnostic Pathology : Neoplastic Dermatopathology (Cassarino). Amirysis Inc. Amirsys Inc, 2012.
22. Wang S. Mycosis Fungoides. In: Diagnostic Pathology : Neoplastic Dermatopathology (Cassarino). Amirsys Inc. Amirys Inc, 2012.
23. Wang S. Langerhans cell histiocytosis. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
24. Wang S, Medeiros LJ. Autoimmune lymphoproliferative disorder. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
25. Wang S. Dermatopathic lymphadenopathy. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
26. Wang S. Langerhans cell Sarcoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
27. Wang S. Enteropathy associated T-cell lymphoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
28. Wang S, Medeiros. Angioimmunoblastic T-cell lymphoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
29. Wang S. Cutaneous B-cell lymphoma leg-type. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
30. Wang S. Whipple's disease. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
31. Wang S. Diagnosis of myelodysplastic syndromes in cytopenic patients. In: Hematol Oncol Clin North Am. 5, 1085-110, vii, 2011.
32. Wang S. Sarcoidosis. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
33. Wang S. Myelodysplastic syndromes and therapy related Myelodysplastic/Myeloproliferative neoplasm. In: Diagnostic Pediatric Hematopathology (Proytcheva M). Cambridge Publisher, 253-71, 2011.
34. Wang, Zota. Inherited and acquired bone marrow failure. In: Diagnostic Pediatric Hematopathology, (Proytcheva M). Cambridge Publisher, 2011.
35. Wang S. Lymphocyte rich Hodgkin's lymphoma. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
36. Wang S. Mycosis Fungoides. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
37. Wang S. Interdigitating dendritic cell tumor. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
38. Wang S. Cytomegalovirsu lymphadenitis. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
39. Wang S. Hemophagocytic syndromes. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
40. Wang S. Sezary Syndrome. In: Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas (Medeiros LJ). Amirsys Inc, 2011.
41. Wang S. Myelodysplastic syndrome, and myelodysplastic/myeloproliferative neoplasm. In: Neoplasatic Hematopathology: Experimental and Clinical Approaches (Contemporary Hematology) (Jones D), 2010.
42. Pozdnyakova O, Bennett JM, DeZern AE, and Wang SA. Myelodysplastic Syndrome. In: The International Consensus Classification of Myeloid and Lymphoid Neoplasms.
43. Horna P, Wang SA. Mature T-Cell and Natural Killer–Cell Leukemias Neoplasms with Leukemic Presentations. In: Hematopathology (Fourth Edition),.
44. Wang SA, Fang H. Flow Cytometry Applications in the Diagnosis and Classification of Aggressive B-Cell Lymphoma. In: Precision Molecular Pathology of Aggressive B-Cell Lymphomas, pp 125–142.

Books (edited and written)

1. Wang SA or Wang S, Wang W. Flow Cytometry In Hematolymphoid Neoplasms, a Comprehensive and Practical Guide to Diagnosis, 2026.
2. Wang Sa, HSI. A Volume in the Series: Foundations in Diagnostic Pathology 4rd Edition, Elsevier, 2025.
3. Wang Sa, Hasserjian P Robert.. Diagnosis of Blood and Bone Marrow Disorders. Springer, 2018.

Letters to the Editor

1. Wang WJ, Wang SA, Fang H, Wei Q, Jorgensen JL, Hu S, Xu J, Li S, Tang G, Tang Z, Medeiros L, Wang W. hallenges and approaches in the diagnosis and differential diagnosis of atypical CLL: A response to 'Defining atypical CLL for reproducible diagnosis: Implications of the work by Wang et al.', 2025.
2. Shuyu, E, Nahmod, KA, Thakral, B, Wang, W, Jorgensen, JL, Wang, S. CD133 in T-lymphoblastic leukemia is preferentially expressed in early T-phenotype (ETP) and near ETP subtypes. Cytometry Part B - Clinical Cytometry 108: 475-478, 2025.
3. Khanlari, M, Wang, S, Tang, G, Saluja, K, Medeiros, LJ, Thakral, B. CD45-negative follicular lymphoma. Cytometry Part B - Clinical Cytometry 100: 406-408, 2021.
4. Wang W, Wang SA, Medeiros LJ, Khoury JD. Response to Dr. Bain's comment on our review article. American journal of hematology 92: E622, 2017.
5. Fadare, O, Wang, S, Hileeto, D. Pure or mixed-type invasive lobular carcinoma-reply. Human Pathology 39: 1121, 2008.
6. Fadare O, S W, Hileeto D. Pure or mixed-type invasive lobular carcinoma-reply. Hum Pathol 39: 1121, 2008.